Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
25000,25000,,,5181990,[],CHEMBL1660393,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322865,>=,1,1,>=,,MIC,ug.mL-1,,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.06
25001,25001,,,5182234,[],CHEMBL1663988,Antimicrobial activity against Proteus mirabilis TUM4660 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649318,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323775,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.12
25002,25002,,,5182235,[],CHEMBL1663989,Antimicrobial activity against Escherichia coli TUM4670 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649318,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323775,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
25003,25003,,,5182236,[],CHEMBL1663990,Antimicrobial activity against Escherichia coli TUM4672 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649318,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323775,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
25004,25004,,,5182237,[],CHEMBL1663991,Antimicrobial activity against Escherichia coli ML4909 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649318,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323775,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
25005,25005,,,5182238,[],CHEMBL1663992,Antimicrobial activity against Escherichia coli ML4901 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649318,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323775,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
25006,25006,,,5182552,[],CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
25007,25007,,,5182558,[],CHEMBL1653406,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,83.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,83.8
25008,25008,,,5182564,[],CHEMBL1653407,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,4.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.2
25009,25009,,,5182570,[],CHEMBL1653408,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,12.0
25010,25010,,,5182577,[],CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,16.0
25011,25011,,,5182583,[],CHEMBL1653410,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,10.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,10.1
25012,25012,,,5182589,[],CHEMBL1653411,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.3
25013,25013,,,5182595,[],CHEMBL1653412,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,89.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,89.6
25014,25014,,,5182602,[],CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,4.0
25015,25015,,,5182608,[],CHEMBL1653414,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,47.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,47.2
25016,25016,,,5182614,[],CHEMBL1653415,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
25017,25017,,,5182620,[],CHEMBL1653416,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,52.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,52.8
25018,25018,,,5182627,[],CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,16.0
25019,25019,,,5182633,[],CHEMBL1653418,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
25020,25020,,,5182639,[],CHEMBL1653419,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
25021,25021,,,5182645,[],CHEMBL1653420,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
25022,25022,,,5182656,[],CHEMBL1653425,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,1.0
25023,25023,,,5182666,[],CHEMBL1653429,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,1.0
25024,25024,,,5182676,[],CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,2.0
25025,25025,,,5182680,[],CHEMBL1653434,Antibacterial activity against Enterococcus faecalis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,38.3,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,38.3
25026,25026,,,5182683,[],CHEMBL1653435,Antibacterial activity against Enterococcus faecalis assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,26.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,26.6
25027,25027,,,5182686,[],CHEMBL1653436,Antibacterial activity against Enterococcus faecalis assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,35.1,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,35.1
25028,25028,,,5182691,[],CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,16.0
25029,25029,,,5182695,[],CHEMBL1653438,Antibacterial activity against Enterococcus faecium assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,12.1,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,12.1
25030,25030,,,5182698,[],CHEMBL1653439,Antibacterial activity against Enterococcus faecium assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,5.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,5.2
25031,25031,,,5182701,[],CHEMBL1653440,Antibacterial activity against Enterococcus faecium assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,82.7,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,82.7
25032,25032,,,5182706,[],CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.06
25033,25033,,,5182710,[],CHEMBL1653443,Antibacterial activity against Escherichia coli assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,75.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,75.2
25034,25034,,,5182714,[],CHEMBL1653445,Antibacterial activity against Escherichia coli assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.3
25035,25035,,,5182718,[],CHEMBL1653447,Antibacterial activity against Escherichia coli assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,24.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,24.5
25036,25036,,,5182723,[],CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.06
25037,25037,,,5182728,[],CHEMBL1653451,Antibacterial activity against Klebsiella pneumoniae assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,92.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,92.5
25038,25038,,,5182733,[],CHEMBL1653453,Antibacterial activity against Klebsiella pneumoniae assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,0.9
25039,25039,,,5182738,[],CHEMBL1653578,Antibacterial activity against Klebsiella pneumoniae assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,6.6,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,6.6
25040,25040,,,5182744,[],CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC50,ug ml-1,UO_0000274,,0.06
25041,25041,,,5182749,[],CHEMBL1653582,Antibacterial activity against Klebsiella oxytoca assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,95.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,95.0
25042,25042,,,5182754,[],CHEMBL1654229,Antibacterial activity against Klebsiella oxytoca assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,2.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,2.0
25043,25043,,,5182759,[],CHEMBL1654231,Antibacterial activity against Klebsiella oxytoca assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,3.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,3.0
25044,25044,,,5182765,[],CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,0.06
25045,25045,,,5182770,[],CHEMBL1654235,Antibacterial activity against Enterobacter cloacae assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,91.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,91.6
25046,25046,,,5182775,[],CHEMBL1654237,Antibacterial activity against Enterobacter cloacae assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,0.6
25047,25047,,,5182780,[],CHEMBL1654239,Antibacterial activity against Enterobacter cloacae assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,7.8,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,7.8
25048,25048,,,5182786,[],CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,0.06
25049,25049,,,5182791,[],CHEMBL1654243,Antibacterial activity against Proteus mirabilis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,82.4,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,82.4
25050,25050,,,5182796,[],CHEMBL1654245,Antibacterial activity against Proteus mirabilis assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,8.4,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,8.4
25051,25051,,,5182801,[],CHEMBL1654366,Antibacterial activity against Proteus mirabilis assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,9.2,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,9.2
25052,25052,,,5182807,[],CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.12
25053,25053,,,5182812,[],CHEMBL1654370,Antibacterial activity against Serratia marcescens assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,88.8,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,88.8
25054,25054,,,5182817,[],CHEMBL1654372,Antibacterial activity against Serratia marcescens assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,3.7,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,3.7
25055,25055,,,5182822,[],CHEMBL1654374,Antibacterial activity against Serratia marcescens assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,7.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,7.5
25056,25056,,,5182828,[],CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,0.5
25057,25057,,,5182832,[],CHEMBL1654378,Antibacterial activity against Pseudomonas aeruginosa assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,66.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,66.0
25058,25058,,,5182836,[],CHEMBL1654380,Antibacterial activity against Pseudomonas aeruginosa assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,11.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,11.0
25059,25059,,,5182840,[],CHEMBL1654382,Antibacterial activity against Pseudomonas aeruginosa assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,23.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,23.4
25060,25060,,,5182846,[],CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,4.0
25061,25061,,,5182852,[],CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,0.25
25062,25062,,,5182856,[],CHEMBL1654388,Antibacterial activity against Acinetobacter baumannii assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,88.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,88.0
25063,25063,,,5182860,[],CHEMBL1654390,Antibacterial activity against Acinetobacter baumannii assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,0.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,0.0
25064,25064,,,5182864,[],CHEMBL1654392,Antibacterial activity against Acinetobacter baumannii assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,12.0
25065,25065,,,5182869,[],CHEMBL1654394,Antibacterial activity against Moraxella catarrhalis by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.06
25066,25066,,,5182872,[],CHEMBL1654396,Antibacterial activity against Moraxella catarrhalis assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1327126,=,1,0,=,,Activity,%,,100.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,%,UO_0000187,,100.0
25067,25067,,,5182875,[],CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25068,25068,,,5182882,[],CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25069,25069,,,5183206,[],CHEMBL1654493,Antimicrobial activity against Klebsiella pneumoniae PFGE clone A expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
25070,25070,,,5183207,[],CHEMBL1654494,Antimicrobial activity against Klebsiella pneumoniae PFGE clone B expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
25071,25071,,,5183208,[],CHEMBL1654495,Antimicrobial activity against Klebsiella pneumoniae PFGE clone C expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
25072,25072,,,5183209,[],CHEMBL1655110,Antimicrobial activity against Klebsiella pneumoniae PFGE clone D expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
25073,25073,,,5183210,[],CHEMBL1655111,Antimicrobial activity against Klebsiella pneumoniae PFGE clone E expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
25074,25074,,,5183211,[],CHEMBL1655112,Antimicrobial activity against Klebsiella pneumoniae PFGE clone F expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,12.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,12.0
25075,25075,,,5183212,[],CHEMBL1655113,Antimicrobial activity against Klebsiella oxytoca expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,32.0
25076,25076,,,5183213,[],CHEMBL1655114,Antimicrobial activity against Enterobacter cloacae expressing beta-lactamase KPC-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649221,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322317,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
25077,25077,,,5183299,[],CHEMBL1660393,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322865,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,4.0
25078,25078,,,5183576,[],CHEMBL1653025,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1322865,=,1,0,=,,Activity,%,,84.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,84.0
25079,25079,,,5183687,[],CHEMBL1664272,Antimicrobial activity against xtended-spectrum-beta-lactamase-producing Escherichia coli obtained from urinary tract infection patient assessed as percent susceptible isolates by Etest,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649322,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1323793,=,1,0,=,,Activity,%,,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,22.0
25080,25080,,,5183840,[],CHEMBL1664540,Antimicrobial activity against Bacillus sp. BS-01 expressing multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces,F,,,BAO_0002146,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323816,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,8.0
25081,25081,,,5183850,[],CHEMBL1664541,Antimicrobial activity against Staphylococcus aureus RN4220 harboring pBS-01multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323816,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
25082,25082,,,5183860,[],CHEMBL1664542,Antimicrobial activity against Staphylococcus aureus RN4220,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649326,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323816,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
25083,25083,,,5183869,[],CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323828,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.064
25084,25084,,,5183878,[],CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323828,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,16.0
25085,25085,,,5183887,[],CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323828,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,64.0
25086,25086,,,5183896,[],CHEMBL1664555,Antimicrobial activity against Acinetobacter baumannii assessed as susceptible isolate by broth dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1323828,=,1,0,=,,Activity,%,,15.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,15.7
25087,25087,,,5183905,[],CHEMBL1664553,Antimicrobial activity against Acinetobacter baumannii assessed as resistant isolate by broth dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1323828,=,1,0,=,,Activity,%,,82.9,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,82.9
25088,25088,,,5183938,[],CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25089,25089,,,5183945,[],CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25090,25090,,,5183953,[],CHEMBL1653425,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25091,25091,,,5183958,[],CHEMBL1653429,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25092,25092,,,5183964,[],CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25093,25093,,,5183970,[],CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25094,25094,,,5183976,[],CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25095,25095,,,5183981,[],CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25096,25096,,,5183987,[],CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC90,ug ml-1,UO_0000274,,0.12
25097,25097,,,5183993,[],CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25098,25098,,,5183999,[],CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25099,25099,,,5184005,[],CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25100,25100,,,5184011,[],CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25101,25101,,,5184017,[],CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25102,25102,,,5184023,[],CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,4.0
25103,25103,,,5184028,[],CHEMBL1654394,Antibacterial activity against Moraxella catarrhalis by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC90,ug.mL-1,,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.06
25104,25104,,,5184033,[],CHEMBL1653405,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
25105,25105,,,5184040,[],CHEMBL1653409,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
25106,25106,,,5184047,[],CHEMBL1653413,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
25107,25107,,,5184054,[],CHEMBL1653417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
25108,25108,,,5184062,[],CHEMBL1653425,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
25109,25109,,,5184067,[],CHEMBL1653429,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
25110,25110,,,5184073,[],CHEMBL1653433,Antibacterial activity against Enterococcus faecalis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
25111,25111,,,5184079,[],CHEMBL1653437,Antibacterial activity against Enterococcus faecium by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,1.0
25112,25112,,,5184085,[],CHEMBL1653441,Antibacterial activity against Escherichia coli by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
25113,25113,,,5184090,[],CHEMBL1653449,Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
25114,25114,,,5184096,[],CHEMBL1653580,Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.06
25115,25115,,,5184102,[],CHEMBL1654233,Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
25116,25116,,,5184108,[],CHEMBL1654241,Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.06
25117,25117,,,5184114,[],CHEMBL1654368,Antibacterial activity against Serratia marcescens by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.06
25118,25118,,,5184120,[],CHEMBL1654376,Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
25119,25119,,,5184126,[],CHEMBL1654384,Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,0.06
25120,25120,,,5184132,[],CHEMBL1654386,Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.12
25121,25121,,,5184137,[],CHEMBL1654394,Antibacterial activity against Moraxella catarrhalis by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327126,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.06
25122,25122,,,5184241,[],CHEMBL1653771,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate VA-566/00 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327142,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,128.0
25123,25123,,,5184242,[],CHEMBL1653772,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate N50 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327142,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,128.0
25124,25124,,,5184243,[],CHEMBL1653773,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate RUH134 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327142,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,1.0
25125,25125,,,5184244,[],CHEMBL1653774,Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate RUH134 harboring plasmid ABVA01 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649555,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327142,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,1.0
25126,25126,,,5184382,[],CHEMBL1654979,Antibacterial activity against Pseudomonas aeruginosa isolate 9BR by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649224,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322329,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
25127,25127,,,5184383,[],CHEMBL1654980,Antibacterial activity against Pseudomonas aeruginosa isolate 19BR by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649224,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322329,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
25128,25128,,,5184384,[],CHEMBL1654981,Antibacterial activity against Pseudomonas aeruginosa isolate 213BR by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649224,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322329,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
25129,25129,,,5184802,[],CHEMBL1653837,Antimicrobial activity against oxacillin-susceptible Staphylococcus haemolyticus clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1322865,=,1,0,=,,Activity,%,,12.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,12.0
25130,25130,,,5189419,[],CHEMBL1659276,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by twofold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649406,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326932,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
25131,25131,,,5189440,[],CHEMBL1659277,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by twofold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649406,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326932,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
25132,25132,,,5189460,[],CHEMBL1659278,Antimycobacterial activity against Mycobacterium smegmatis MC2 155 after 72 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649406,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326932,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.125
25133,25133,,,5189479,[],CHEMBL1659279,Antimycobacterial activity against Mycobacterium bovis BCG after 7 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649406,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326932,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
25134,25134,,,5189822,[],CHEMBL1659576,Antimycobacterial activity against Mycobacterium smegmatis CMCC 93202 after 72 hrs by serial double dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649408,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1327207,=,1,1,=,,MIC,nM,,2360.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.36
25135,25135,,,5189841,[],CHEMBL1659577,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by serial double dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649408,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1327207,=,1,1,=,,MIC,nM,,970.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.97
25136,25136,,,5189855,[],CHEMBL1659578,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 09710 after 7 days by serial double dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649408,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1327207,=,1,1,=,,MIC,nM,,24170.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,24.17
25137,25137,,,5189874,[],CHEMBL1659579,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assat,A,,,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649408,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1327207,=,1,1,=,,CC50,nM,,600800.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,CC50,uM,UO_0000065,,600.8
25138,25138,,,5189893,[],CHEMBL1659580,"Selectivity index, ratio of CC50 for african green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv ATCC 27294",F,,,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1649408,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1327207,=,1,0,=,,Selectivity Index,,,619.0,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,619.0
25139,25139,,,5194820,[],CHEMBL1670586,Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth micro dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
25140,25140,,,5194839,[],CHEMBL1670587,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by broth micro dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
25141,25141,,,5194873,[],CHEMBL1671526,Antibacterial activity against Streptococcus hemolyticus 1002 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,64.0
25142,25142,,,5194894,[],CHEMBL1671527,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
25143,25143,,,5194915,[],CHEMBL1671528,Antibacterial activity against Escherichia coli 10-02 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25144,25144,,,5194936,[],CHEMBL1671529,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
25145,25145,,,5194957,[],CHEMBL1671530,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
25146,25146,,,5194978,[],CHEMBL1671531,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
25147,25147,,,5196318,[],CHEMBL1670588,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by broth micro dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
25148,25148,,,5196337,[],CHEMBL1670589,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 12228 by broth micro dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
25149,25149,,,5196348,[],CHEMBL1670590,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
25150,25150,,,5196359,[],CHEMBL1670591,Antibacterial activity against methicillin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
25151,25151,,,5196370,[],CHEMBL1670592,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
25152,25152,,,5196381,[],CHEMBL1670593,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
25153,25153,,,5196392,[],CHEMBL1670594,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25154,25154,,,5196403,[],CHEMBL1670595,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25155,25155,,,5196414,[],CHEMBL1670596,Antibacterial activity against Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667756,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328476,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.125
25156,25156,,,5197713,[],CHEMBL1670848,Antimicrobial activity against wild type Escherichia coli by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667853,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328167,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
25157,25157,,,5197721,[],CHEMBL1670849,Antimicrobial activity against multidrug-resistant Escherichia coli by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667853,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328167,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
25158,25158,,,5197730,[],CHEMBL1670850,Antimicrobial activity against ESBL producing Escherichia coli by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667853,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328167,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
25159,25159,,,5197736,[],CHEMBL1670851,Antimicrobial activity against wild type Pseudomonas aeruginosa by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667853,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328167,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.012
25160,25160,,,5197745,[],CHEMBL1670852,Antimicrobial activity against multidrug-resistant Pseudomonas aeruginosa by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667853,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328167,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
25161,25161,,,5197754,[],CHEMBL1670853,Antimicrobial activity against wild type Klebsiella pneumoniae by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667853,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328167,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
25162,25162,,,5197794,[],CHEMBL1670862,Antimicrobial activity against wild type Stenotrophomonas maltophilia by broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667853,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1328167,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,0.016
25163,25163,,,5205490,[],CHEMBL1670199,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667806,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329255,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.39
25164,25164,,,5205499,[],CHEMBL1670200,Antimycobacterial activity against Mycobacterium bovis BCG str. Tokyo 172,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667806,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329255,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.1
25165,25165,,,5205516,[],CHEMBL1670202,Antimycobacterial activity against Mycobacterium avium subsp. hominissuis 104,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667806,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329255,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.39
25166,25166,,,5205527,[],CHEMBL1670203,Antimycobacterial activity against Mycobacterium avium subsp. avium ATCC 2529I,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667806,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329255,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,1.56
25167,25167,,,5205538,[],CHEMBL1670204,Antimicrobial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667806,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329255,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
25168,25168,,,5205565,[],CHEMBL1670206,Antimicrobial activity against Escherichia coli DH5alpha,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667806,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329255,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
25169,25169,,,5206324,[],CHEMBL1671222,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
25170,25170,,,5206345,[],CHEMBL1671223,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-04 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
25171,25171,,,5206366,[],CHEMBL1671224,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-05 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
25172,25172,,,5206387,[],CHEMBL1671225,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-4 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
25173,25173,,,5206408,[],CHEMBL1671226,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-5 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
25174,25174,,,5206429,[],CHEMBL1671525,Antibacterial activity against Streptococcus pneumoniae 1001 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329323,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
25175,25175,,,5209823,[],CHEMBL1678977,Antimicrobial activity against ESBL producing Escherichia coli isolated from patient bloodstream assessed as resistant isolate by Etest method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671616,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1331734,=,1,0,=,,Activity,%,,92.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,92.2
25176,25176,,,5210031,[],CHEMBL1674368,Antimicrobial activity against Pseudomonas aeruginosa PAO1 biofilm by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25177,25177,,,5210032,[],CHEMBL1674369,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMS biofilm by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25178,25178,,,5210033,[],CHEMBL1674370,Antimicrobial activity against mucA::lox-deficient Pseudomonas aeruginosa PAOMA biofilm by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25179,25179,,,5210034,[],CHEMBL1674371,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSA biofilm by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25180,25180,,,5210035,[],CHEMBL1674372,Antimicrobial activity against nfxB gene-deficient Pseudomonas aeruginosa PAONB biofilm by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
25181,25181,,,5210036,[],CHEMBL1674373,"Antimicrobial activity against mutS::lox,nfxB gene-deficient Pseudomonas aeruginosa PAOMSNB biofilm by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
25182,25182,,,5210037,[],CHEMBL1674374,Antimicrobial activity against mexD::lox-deficient Pseudomonas aeruginosa PAOMxD biofilm by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25183,25183,,,5210038,[],CHEMBL1674375,"Antimicrobial activity against mutS::lox,mexD::lox-deficient Pseudomonas aeruginosa PAOMSMxD biofilm by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.094
25184,25184,,,5210039,[],CHEMBL1674376,Antimicrobial activity against Pseudomonas aeruginosa PAO1 A biofilm harboring duplication mutation at nucleotide 333 in nfxB gene selected at 0.5 ug/ml of azithromycin by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25185,25185,,,5210040,[],CHEMBL1674377,Antimicrobial activity against Pseudomonas aeruginosa PAO1 A biofilm harboring deletion mutation at nucleotide 231-244 in nfxB gene selected at 1 ug/ml of azithromycin after 4 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25186,25186,,,5210041,[],CHEMBL1674378,Antimicrobial activity against Pseudomonas aeruginosa PAO1 A biofilm harboring nfxB T248C mutant gene selected at 4 ug/ml of azithromycin after 4 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25187,25187,,,5210042,[],CHEMBL1674379,Antimicrobial activity against mucA::lox-deficient Pseudomonas aeruginosa PAOMAB biofilm harboring nfxB G125T mutant gene selected at 0.5 ug/ml of azithromycin after 1 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25188,25188,,,5210043,[],CHEMBL1674380,Antimicrobial activity against mucA::lox-deficient Pseudomonas aeruginosa PAOMAA biofilm harboring nfxB C25T mutant gene selected at 1 ug/ml of azithromycin after 2 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25189,25189,,,5210044,[],CHEMBL1674381,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSB biofilm harboring nfxB T380C mutant gene selected at 0.5 ug/ml of azithromycin after 2 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
25190,25190,,,5210045,[],CHEMBL1674507,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSA biofilm harboring nfxB C116T mutant gene selected at 1 ug/ml of azithromycin after 1 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
25191,25191,,,5210046,[],CHEMBL1674508,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSA biofilm harboring nfxB T533C mutant gene selected at 4 ug/ml of azithromycin after 2 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25192,25192,,,5210047,[],CHEMBL1674509,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSB biofilm harboring deletion od C534 in nfxB mutant gene selected at 4 ug/ml of azithromycin after 2 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25193,25193,,,5210048,[],CHEMBL1674510,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSA biofilm harboring nfxB T86C mutant gene selected at 4 ug/ml of azithromycin after 3 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25194,25194,,,5210049,[],CHEMBL1674511,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSB biofilm harboring nfxB T41C mutant gene selected at 4 ug/ml of azithromycin after 3 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25195,25195,,,5210050,[],CHEMBL1674512,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSA biofilm harboring nfxB T86C mutant gene selected at 4 ug/ml of azithromycin after 4 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
25196,25196,,,5210051,[],CHEMBL1674513,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSB biofilm harboring nfxB T562C mutant gene selected at 4 ug/ml of azithromycin after 4 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.75
25197,25197,,,5210052,[],CHEMBL1674514,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSA biofilm harboring nfxB G461A mutant gene selected at 4 ug/ml of azithromycin after 5 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
25198,25198,,,5210053,[],CHEMBL1674515,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSB biofilm harboring nfxB C116T mutant gene selected at 4 ug/ml of azithromycin after 5 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.5
25199,25199,,,5210054,[],CHEMBL1674516,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSA biofilm harboring nfxB G539A mutant gene selected at 4 ug/ml of azithromycin after 6 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
25200,25200,,,5210055,[],CHEMBL1674517,Antimicrobial activity against mutS::lox-deficient Pseudomonas aeruginosa PAOMSB biofilm harboring nfxB T77C mutant gene selected at 4 ug/ml of azithromycin after 6 passages by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
25201,25201,,,5210056,[],CHEMBL1674518,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAA biofilm harboring nfxB C89T mutant gene selected at 0.5 ug/ml of azithromycin after 3 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25202,25202,,,5210057,[],CHEMBL1674519,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAB biofilm harboring nfxB C25T mutant gene selected at 1 ug/ml of azithromycin after 2 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25203,25203,,,5210058,[],CHEMBL1674520,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAB biofilm harboring nfxB T544C mutant gene selected at 4 ug/ml of azithromycin after 1 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25204,25204,,,5210059,[],CHEMBL1675308,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAA biofilm harboring nfxB T86C mutant gene selected at 4 ug/ml of azithromycin after 2 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25205,25205,,,5210060,[],CHEMBL1675309,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAB biofilm harboring nfxB T86C mutant gene selected at 4 ug/ml of azithromycin after 2 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25206,25206,,,5210061,[],CHEMBL1675310,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAA biofilm harboring nfxB T77C mutant gene selected at 4 ug/ml of azithromycin after 3 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25207,25207,,,5210062,[],CHEMBL1675311,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAA biofilm harboring nfxB C89T mutant gene selected at 4 ug/ml of azithromycin after 6 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
25208,25208,,,5210063,[],CHEMBL1675312,"Antimicrobial activity against mucA::lox, mutS::lox-deficient Pseudomonas aeruginosa PAOMSAB biofilm harboring nfxB C89T mutant gene selected at 4 ug/ml of azithromycin after 6 passages by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671651,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25209,25209,,,5210720,[],CHEMBL1676038,Antibacterial activity against wild type Pseudomonas aeruginosa PAK assessed as viable bacterial count by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
25210,25210,,,5210721,[],CHEMBL1677626,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as viable bacterial count by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
25211,25211,,Not Active,5210722,[],CHEMBL1676037,Antibacterial activity against wild type Pseudomonas aeruginosa PAK assessed as viable bacterial count at 0.5 times MIC after 48 hrs by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
25212,25212,,,5210723,[],CHEMBL1677627,Antibacterial activity against wild type Pseudomonas aeruginosa PAK assessed as viable bacterial count at 0.5 times MIC after 40 hrs by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
25213,25213,,,5210724,[],CHEMBL1676039,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as viable bacterial count at 2 times MIC after 48 hrs by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
25214,25214,,,5210725,[],CHEMBL1676033,Ratio of MIC for wild type Pseudomonas aeruginosa PAK to Pseudomonas aeruginosa PAK-F5,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,=,1,0,=,,Ratio,,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Ratio,,,,8.0
25215,25215,,,5210726,[],CHEMBL1676034,Ratio of MIC for wild type Pseudomonas aeruginosa PAO1 to Pseudomonas aeruginosa PAO1 horboring mmsA mutant gene,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,=,1,0,=,,Ratio,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Ratio,,,,4.0
25216,25216,,Not Active,5210729,[],CHEMBL1677628,Antibacterial activity against Pseudomonas aeruginosa PAO1 horboring gabD mutant gene assessed as viable bacterial count at 4 times MIC after 24 hrs by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
25217,25217,,Active,5210730,[],CHEMBL1677629,Antibacterial activity against Pseudomonas aeruginosa PAO1 horboring gabD mutant gene assessed as viable bacterial count at 8 times MIC after 48 hrs by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
25218,25218,,Not Active,5210731,[],CHEMBL1677630,Antibacterial activity against Pseudomonas aeruginosa PAO1 horboring mmsA mutant gene assessed as viable bacterial count at 4 times MIC after 24 hrs by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
25219,25219,,Active,5210732,[],CHEMBL1676030,Antibacterial activity against Pseudomonas aeruginosa PAO1 horboring mmsA mutant gene assessed as viable bacterial count at 8 times MIC after 48 hrs by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
25220,25220,,Active,5210733,[],CHEMBL1676031,Antibacterial activity against Pseudomonas aeruginosa PAO1 horboring yaaA mutant gene assessed as viable bacterial count at 4 times MIC after 24 hrs by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
25221,25221,,Active,5210734,[],CHEMBL1676032,Antibacterial activity against Pseudomonas aeruginosa PAO1 horboring yaaA mutant gene assessed as viable bacterial count at 8 times MIC after 48 hrs by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332598,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
25222,25222,,,5210735,[],CHEMBL1676040,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gatA::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.19
25223,25223,,,5210736,[],CHEMBL1676041,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring phoU::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
25224,25224,,,5210737,[],CHEMBL1676042,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25225,25225,,,5210738,[],CHEMBL1676043,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring mmsA::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25226,25226,,,5210739,[],CHEMBL1676044,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring yaaA::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25227,25227,,,5210740,[],CHEMBL1676045,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISlacZ/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332598,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
25228,25228,,,5210777,[],CHEMBL1676046,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB018 with PFGE subgroup G containing carbapenemase OXA-58 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25229,25229,,,5210783,[],CHEMBL1676047,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB039 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25230,25230,,,5210789,[],CHEMBL1676048,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB095 with PFGE subgroup E containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25231,25231,,,5210795,[],CHEMBL1676049,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB110 with PFGE subgroup C containing carbapenemase OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25232,25232,,,5210801,[],CHEMBL1676050,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB127 with PFGE subgroup I containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25233,25233,,,5210807,[],CHEMBL1676051,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB166 with PFGE subgroup A3 containing carbapenemase OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25234,25234,,,5210813,[],CHEMBL1676052,Antibacterial activity against intI1-negative tigecycline-intermediate Acinetobacter baumannii AB098 with PFGE subgroup F containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25235,25235,,,5210819,[],CHEMBL1676053,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB099 with PFGE subgroup H containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25236,25236,,,5210825,[],CHEMBL1676054,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB106 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25237,25237,,,5210831,[],CHEMBL1676055,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB113 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25238,25238,,,5210837,[],CHEMBL1676056,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB118 with PFGE subgroup B2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25239,25239,,,5210843,[],CHEMBL1676057,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB125 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25240,25240,,,5210849,[],CHEMBL1676058,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB134 with PFGE subgroup A2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25241,25241,,,5210855,[],CHEMBL1676059,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB168 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25242,25242,,,5210861,[],CHEMBL1676060,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB173 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25243,25243,,,5210867,[],CHEMBL1676061,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB097 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25244,25244,,,5210873,[],CHEMBL1676062,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB096 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332604,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
25245,25245,,,5211676,[],CHEMBL1678783,"Antimicrobial activity against Escherichia coli isolate 157 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 3 isolated from urine of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25246,25246,,,5211677,[],CHEMBL1678784,Antimicrobial activity against Escherichia coli isolate 157T expressing beta-lactamase KPC2 and PFGE cluster 3 isolated from urine of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25247,25247,,,5211678,[],CHEMBL1678785,"Antimicrobial activity against Escherichia coli isolate 329 expressing beta-lactamase KPC2, CTX-M-2, TEM and PFGE cluster 2 isolated from blood of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25248,25248,,,5211679,[],CHEMBL1678786,Antimicrobial activity against Escherichia coli isolate 329T expressing beta-lactamase KPC2 and PFGE cluster 2 isolated from blood of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25249,25249,,,5211680,[],CHEMBL1674594,"Antimicrobial activity against Escherichia coli isolate 339 expressing beta-lactamase KPC2, TEM and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25250,25250,,,5211681,[],CHEMBL1674595,Antimicrobial activity against Escherichia coli isolate 339T expressing beta-lactamase KPC2 and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25251,25251,,,5211682,[],CHEMBL1674596,"Antimicrobial activity against Escherichia coli isolate 360 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from urine of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25252,25252,,,5211683,[],CHEMBL1674597,"Antimicrobial activity against Escherichia coli isolate 360T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from urine of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25253,25253,,,5211684,[],CHEMBL1674598,"Antimicrobial activity against Escherichia coli isolate 386 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from wound of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25254,25254,,,5211685,[],CHEMBL1674599,"Antimicrobial activity against Escherichia coli isolate 386T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from wound of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25255,25255,,,5211686,[],CHEMBL1674600,"Antimicrobial activity against Escherichia coli isolate 540 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25256,25256,,,5211687,[],CHEMBL1674601,"Antimicrobial activity against Escherichia coli isolate 543 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25257,25257,,,5211688,[],CHEMBL1674602,Antimicrobial activity against Escherichia coli isolate 543T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25258,25258,,,5211689,[],CHEMBL1674603,"Antimicrobial activity against Escherichia coli isolate 544 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from abscess of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25259,25259,,,5211690,[],CHEMBL1674604,"Antimicrobial activity against Escherichia coli isolate 547 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from blood of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25260,25260,,,5211691,[],CHEMBL1674605,Antimicrobial activity against Escherichia coli isolate 547T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from blood of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25261,25261,,,5211692,[],CHEMBL1674606,"Antimicrobial activity against Escherichia coli isolate 1679 expressing beta-lactamase KPC2, SHV-12, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
25262,25262,,,5211693,[],CHEMBL1674607,"Antimicrobial activity against Escherichia coli isolate 1679T expressing beta-lactamase KPC2, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25263,25263,,,5211694,[],CHEMBL1674608,Antimicrobial activity against Escherichia coli DH10B by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332141,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25264,25264,,,5212238,[],CHEMBL1675069,Antimicrobial activity against community-associated methicillin-resistant Staphylococcus aureus USA300,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332666,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
25265,25265,,,5212249,[],CHEMBL1675070,Antimicrobial activity against community-associated methicillin-resistant Staphylococcus aureus Sanger 252,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332666,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
25266,25266,,Not Active,5212266,[],CHEMBL1675075,Decrease in delta toxin levels in Staphylococcus aureus Sanger 252 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332666,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
25267,25267,,Not Active,5212275,[],CHEMBL1675076,Decrease in delta toxin levels in Staphylococcus aureus USA300 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332666,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
25268,25268,,Active,5212284,[],CHEMBL1675078,Decrease in PSMbeta1 levels in Staphylococcus aureus USA300 at subinhibitory concentration after 24 hrs by RP-HPLC/ESI-MS,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332666,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
25269,25269,,Active,5212293,[],CHEMBL1675077,Decrease in PSMbeta1 levels in Staphylococcus aureus Sanger 252 at subinhibitory concentrations after 24 hrs by RP-HPLC/ESI- MS,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671748,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332666,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
25270,25270,,,5212393,[],CHEMBL1680768,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331746,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
25271,25271,,,5212394,[],CHEMBL1680772,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331746,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
25272,25272,,,5212395,[],CHEMBL1680771,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331746,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
25273,25273,,Active,5212461,[],CHEMBL1680770,Activity of Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation by fluorimetric assay,B,,,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331746,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
25274,25274,,Active,5212462,[],CHEMBL1680769,Activity of Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation by fluorimetric assay,B,,,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331746,,1,0,,,Activity,,,,CHEMBL1681613,Escherichia coli (strain K12),Multidrug resistance protein mdtK,83333.0,,,Activity,,,,
25275,25275,,,5212475,[],CHEMBL1680778,Binding affinity to Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay,B,,,BAO_0000034,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1331746,=,1,1,=,,Kd,nM,,121300.0,CHEMBL612545,,Unchecked,,,,Kd,uM,UO_0000065,,121.3
25276,25276,,,5212479,[],CHEMBL1681165,Binding affinity to Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay,B,,,BAO_0000034,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,"{'bei': '12.20', 'le': '0.23', 'lle': '2.46', 'sei': '5.42'}",CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.04,0,http://www.openphacts.org/units/Nanomolar,1331746,=,1,1,=,,Kd,nM,,90900.0,CHEMBL1681613,Escherichia coli (strain K12),Multidrug resistance protein mdtK,83333.0,,,Kd,uM,UO_0000065,,90.9
25277,25277,,,5213568,[],CHEMBL1676946,Ratio of MIC for Vibrio cholerae O1 CIP0.25-1 to MIC for Vibrio cholerae O1 569B,F,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332688,=,1,0,=,,Ratio,,,250.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,Ratio,,,,250.0
25278,25278,,,5213569,[],CHEMBL1676948,Antibacterial activity against Vibrio cholerae O1 569B harboring gyrA and parC genes by 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332688,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.004
25279,25279,,,5213570,[],CHEMBL1676949,Antibacterial activity against Vibrio cholerae O1 CIP0.25-1 harboring Ser to Ile mutation at 83 position in gyrA and parC genes by 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332688,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
25280,25280,,,5213571,[],CHEMBL1676950,Antibacterial activity against Vibrio cholerae O1 mTn-321 harboring Ser to Ile mutation at 83 position in gyrA and parC genes by 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332688,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.0625
25281,25281,,,5213584,[],CHEMBL1676947,Ratio of MIC for Vibrio cholerae O1 CIP0.25-1 to MIC for Vibrio cholerae O1 mTn-321,F,,,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332688,=,1,0,=,,Ratio,,,16.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,Ratio,,,,16.0
25282,25282,,,5213585,[],CHEMBL1676951,Antibacterial activity against Escherichia coli JM109 harboring plasmid ptac85,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332688,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25283,25283,,,5213586,[],CHEMBL1676952,Antibacterial activity against Escherichia coli JM109 harboring plasmid ptac85-vca0421,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332688,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25284,25284,,,5214793,[],CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,2.0
25285,25285,,,5214794,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
25286,25286,,,5214808,[],CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,8.0
25287,25287,,,5214809,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,16.0
25288,25288,,,5214823,[],CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25289,25289,,,5214824,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,32.0
25290,25290,,,5214871,[],CHEMBL1677452,Antibacterial activity against ESBL-producing Klebsiella pneumoniae by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671765,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332741,>,1,1,>,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
25291,25291,,,5214872,[],CHEMBL1677452,Antibacterial activity against ESBL-producing Klebsiella pneumoniae by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671765,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332741,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.125
25292,25292,,,5214873,[],CHEMBL1677452,Antibacterial activity against ESBL-producing Klebsiella pneumoniae by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671765,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332741,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25293,25293,,,5214874,[],CHEMBL1677453,Antibacterial activity against plasmid-mediated AmpC beta-Lactamase DHA-1 and ESBL-producing Klebsiella pneumoniae by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671765,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332741,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25294,25294,,,5214875,[],CHEMBL1677453,Antibacterial activity against plasmid-mediated AmpC beta-Lactamase DHA-1 and ESBL-producing Klebsiella pneumoniae by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671765,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332741,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
25295,25295,,,5214876,[],CHEMBL1677453,Antibacterial activity against plasmid-mediated AmpC beta-Lactamase DHA-1 and ESBL-producing Klebsiella pneumoniae by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671765,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332741,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
25296,25296,,,5215122,[],CHEMBL1676103,Inhibition of human ERG,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1671772,Eur J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/Nanomolar,1332784,=,1,1,=,,IC50,nM,,954992.59,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.02
25297,25297,,,5215845,[],CHEMBL1677408,Antibacterial activity against Listeria monocytogenes isolated from humans harboring lde gene,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671693,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332177,>,1,1,>,,MIC,ug.mL-1,,6.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,6.0
25298,25298,,,5217670,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
25299,25299,,,5217678,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
25300,25300,,,5217686,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25301,25301,,,5217694,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
25302,25302,,,5217702,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.06
25303,25303,,,5217710,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.06
25304,25304,,,5217718,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25305,25305,,,5217726,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,32.0
25306,25306,,,5217734,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.125
25307,25307,,,5217742,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,8.0
25308,25308,,,5217750,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
25309,25309,,,5217758,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,64.0
25310,25310,,,5217766,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25311,25311,,,5217774,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,32.0
25312,25312,,,5217782,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25313,25313,,,5217790,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
25314,25314,,,5217798,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.06
25315,25315,,,5217806,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,1.0
25316,25316,,,5217814,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,0.5
25317,25317,,,5217822,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,1.0
25318,25318,,,5217830,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,2.0
25319,25319,,,5217838,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,4.0
25320,25320,,,5217846,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC50,ug ml-1,UO_0000274,,4.0
25321,25321,,,5217854,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25322,25322,,,5217862,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,64.0
25323,25323,,,5217870,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,64.0
25324,25324,,,5217878,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332734,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,4.0
25325,25325,,,5218690,[],CHEMBL1676029,Antimicrobial activity against Escherichia coli C600::933W in stationary phase encoding Stx-2 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
25326,25326,,,5218699,[],CHEMBL1676028,Antimicrobial activity against Escherichia coli C600::933W in logarithmic phase encoding Stx-2 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
25327,25327,,,5218708,[],CHEMBL1676026,Antimicrobial activity against Escherichia coli C600::H19B in stationary phase encoding Stx-1 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
25328,25328,,,5218717,[],CHEMBL1676027,Antimicrobial activity against Escherichia coli C600::H19B in logarithmic phase encoding Stx-1 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
25329,25329,,,5218726,[],CHEMBL1676025,Antimicrobial activity against Escherichia coli O157:H7 PT-32 in stationary phase encoding Stx-1 and Stx-2 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
25330,25330,,,5218735,[],CHEMBL1678356,Antimicrobial activity against Escherichia coli O157:H7 PT-32 in logarithmic phase encoding Stx-1 and Stx-2 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
25331,25331,,,5218744,[],CHEMBL1678355,Antimicrobial activity against Escherichia coli O157:H7 PT-40 in stationary phase encoding Stx-2 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
25332,25332,,,5218753,[],CHEMBL1678354,Antimicrobial activity against Escherichia coli O157:H7 PT-40 in logarithmic phase encoding Stx-2 gene by broth macrodilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332340,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
25333,25333,,Active,5218762,[],CHEMBL1678353,Increase in shiga toxin production in Escherichia coli O157:H7 PT-32 encoding Stx-1 and Stx-2 gene at subinhibitory concentration by luciferase assay relative to untreated control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25334,25334,,Not Active,5218764,[],CHEMBL1678352,Increase in shiga toxin production in Escherichia coli O157:H7 PT-40 encoding Stx-2 gene at 0.5 X MIC by luciferase assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25335,25335,,Not Active,5218766,[],CHEMBL1678351,Increase in shiga toxin production in Escherichia coli O157:H7 PT-32 encoding Stx-1 and Stx-2 gene at 0.5 X MIC by luciferase assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25336,25336,,Active,5218768,[],CHEMBL1678350,Increase in shiga toxin production in Escherichia coli C600::933W encoding Stx-2 gene at 0.5 X MIC by luciferase assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25337,25337,,Active,5218770,[],CHEMBL1678349,Increase in shiga toxin production in Escherichia coli C600::H19B encoding Stx-1 gene at 0.5 X MIC by luciferase assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25338,25338,,Not Active,5218772,[],CHEMBL1678348,Increase in Stx2 gene expression in Escherichia coli O157:H7 PT-32 at 0.5 X MIC by ELISA,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25339,25339,,Not Active,5218791,[],CHEMBL1678342,Antimicrobial activity against Escherichia coli O157:H7 185 cocultured with Stx-phage susceptible Escherichia coli isolate CMUC-170 relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25340,25340,,Not Active,5218795,[],CHEMBL1678341,Increase in Stx2 gene expression in Escherichia coli O157:H7 185 cocultured with Stx-phage susceptible Escherichia coli isolate CMUC-170 at 0.015 ug/ml by luciferase assay relative to untreated control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25341,25341,,Active,5218798,[],CHEMBL1678340,Antimicrobial activity against Escherichia coli O157:H7 185 cocultured with Stx-phage susceptible Escherichia coli isolate CMUC-170 at > 0.05 ug/ml by luciferase assay relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25342,25342,,Not Active,5218799,[],CHEMBL1678339,Increase in shiga toxin production in Escherichia coli O157:H7 185 encoding stx gene cocultured with Stx-phage susceptible Escherichia coli isolate CMUC-170 at 0.44 ug/ml by luciferase assay relative to untreated control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25343,25343,,Active,5218800,[],CHEMBL1678338,Decrease in shiga toxin production in Escherichia coli O157:H7 185 encoding stx gene cocultured with Stx-phage susceptible Escherichia coli isolate CMUC-170 at 4 ug/ml by luciferase assay relative to untreated control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25344,25344,,Active,5218802,[],CHEMBL1678337,Decrease in shiga toxin production in Escherichia coli O157:H7 185 encoding stx gene cocultured with Stx-phage susceptible Escherichia coli isolate CMUC-170 at 8 to 16 ug/ml by luciferase assay relative to untreated control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671710,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332340,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25345,25345,,,5222449,[],CHEMBL1674471,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2017 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.25
25346,25346,,,5222450,[],CHEMBL1674470,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Stanley isolate s2018 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
25347,25347,,,5222451,[],CHEMBL1674469,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2052 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
25348,25348,,,5222452,[],CHEMBL1674468,Antimicrobial activity against qnrA-positive Salmonella enterica serovar Mbandaka isolate s2093 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,4.0
25349,25349,,,5222453,[],CHEMBL1674467,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2209 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
25350,25350,,,5222454,[],CHEMBL1674466,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Virginia isolate s2219 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
25351,25351,,,5222455,[],CHEMBL1674465,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2425 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
25352,25352,,,5222456,[],CHEMBL1674464,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2705 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
25353,25353,,,5222457,[],CHEMBL1674463,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Braenderup isolate s2856 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
25354,25354,,,5222458,[],CHEMBL1674462,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2944 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
25355,25355,,,5222459,[],CHEMBL1674461,Antimicrobial activity against Salmonella enterica serovar Stanley isolate s2043 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
25356,25356,,,5222460,[],CHEMBL1674340,Antimicrobial activity against Salmonella enterica serovar Corvallis isolate s2064 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
25357,25357,,,5222461,[],CHEMBL1674339,Antimicrobial activity against Salmonella enterica serovar Mbandaka isolate s2159 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.008
25358,25358,,,5222462,[],CHEMBL1674338,Antimicrobial activity against Salmonella enterica serovar Montevideo isolate s2317 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
25359,25359,,,5222463,[],CHEMBL1674337,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate s2878 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
25360,25360,,,5222464,[],CHEMBL1674336,Antimicrobial activity against Salmonella enterica serovar Braenderup isolate s2906 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
25361,25361,,,5222465,[],CHEMBL1674335,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate SL1344 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
25362,25362,,,5222517,[],CHEMBL1674334,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Corvallis isolate s2017 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25363,25363,,Not Determined,5222518,[],CHEMBL1674333,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Stanley isolate s2018 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25364,25364,,,5222519,[],CHEMBL1674332,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Corvallis isolate s2052 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25365,25365,,Not Determined,5222520,[],CHEMBL1674331,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Mbandaka isolate s2093 plasmid encoded qnrA and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25366,25366,,,5222521,[],CHEMBL1674330,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Montevideo isolate s2209 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25367,25367,,,5222522,[],CHEMBL1674329,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Virginia isolate s2219 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25368,25368,,,5222523,[],CHEMBL1674328,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate s2425 plasmid encoded qnrS and Parc gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25369,25369,,,5222524,[],CHEMBL1674327,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate s2705 plasmid encoded qnrS and Parc gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25370,25370,,Not Determined,5222525,[],CHEMBL1674326,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Braenderup isolate s2856 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25371,25371,,,5222526,[],CHEMBL1674325,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Montevideo isolate s2944 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332013,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25372,25372,,Not Determined,5222527,[],CHEMBL1674324,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Stanley isolate s2043 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25373,25373,,Not Determined,5222528,[],CHEMBL1674472,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Corvallis isolate s2064 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25374,25374,,Not Determined,5222529,[],CHEMBL1674473,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Mbandaka isolate s2159 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25375,25375,,Not Determined,5222530,[],CHEMBL1674474,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Montevideo isolate s2317 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25376,25376,,Not Determined,5222531,[],CHEMBL1674475,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate s2878 plasmid encoded Parc gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25377,25377,,Not Determined,5222532,[],CHEMBL1674476,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Braenderup isolate s2906 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25378,25378,,Not Determined,5222533,[],CHEMBL1675263,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate SL1344 plasmid encoded Parc gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
25379,25379,,Not Active,5222534,[],CHEMBL1675264,Drug uptake in qnrA-positive Salmonella enterica serovar Mbandaka isolate s2093 harboring ParC QRDR mutant gene in presence of CCCP,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,Drug uptake,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Drug uptake,,,,
25380,25380,,Not Active,5222535,[],CHEMBL1675265,Drug uptake in qnrS-positive Salmonella enterica serovar Montevideo isolate s2209 harboring ParC QRDR mutant gene in presence of CCCP,F,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332013,,1,0,,,Drug uptake,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Drug uptake,,,,
25381,25381,,,5223857,[],CHEMBL1673729,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR after 24 hrs by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,1,=,,MIC,ug.mL-1,,0.075,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.075
25382,25382,,,5223858,[],CHEMBL1673730,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 after 24 hrs by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25383,25383,,,5223859,[],CHEMBL1673731,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 after 24 hrs by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25384,25384,,,5223860,[],CHEMBL1673732,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene after 24 hrs by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25385,25385,,,5223861,[],CHEMBL1673733,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR assessed as concentration required to prevent mutation after 72 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,0,=,,Activity,ug ml-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,0.06
25386,25386,,,5223862,[],CHEMBL1673734,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 assessed as concentration required to prevent mutation after 72 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
25387,25387,,,5223863,[],CHEMBL1673735,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 assessed as concentration required to prevent mutation after 72 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,2.0
25388,25388,,,5223864,[],CHEMBL1673736,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene assessed as concentration required to prevent mutation after 72 hrs",F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,2.0
25389,25389,,,5223865,[],CHEMBL1673737,"Ratio of MPC to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
25390,25390,,,5223866,[],CHEMBL1673738,"Ratio of MPC to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
25391,25391,,,5223867,[],CHEMBL1673739,"Ratio of MPC to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
25392,25392,,,5223868,[],CHEMBL1673740,"Ratio of MPC to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
25393,25393,,Active,5223869,[],CHEMBL1673741,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR at 0.5 ug/ml after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25394,25394,,Not Active,5223870,[],CHEMBL1673742,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 at 0.5 ug/ml after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25395,25395,,Not Active,5223871,[],CHEMBL1673743,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 at 0.5 ug/ml after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25396,25396,,Not Active,5223872,[],CHEMBL1673744,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene at 0.5 ug/ml after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25397,25397,,Active,5223873,[],CHEMBL1673745,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR at 0.5 ug/ml after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25398,25398,,Not Active,5223874,[],CHEMBL1673746,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 at 0.5 ug/ml after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25399,25399,,Not Active,5223875,[],CHEMBL1673747,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 at 0.5 ug/ml after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25400,25400,,Not Active,5223876,[],CHEMBL1673748,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene at 0.5 ug/ml after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25401,25401,,Active,5223877,[],CHEMBL1673749,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR at 0.5 ug/ml after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25402,25402,,Not Active,5223878,[],CHEMBL1673750,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 at 0.5 ug/ml after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25403,25403,,Not Active,5223879,[],CHEMBL1673751,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 at 0.5 ug/ml after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25404,25404,,Not Active,5223880,[],CHEMBL1673752,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene at 0.5 ug/ml after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25405,25405,,Active,5223881,[],CHEMBL1673753,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR at 4 times MIC after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25406,25406,,Not Active,5223882,[],CHEMBL1673754,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 at 4 times MIC after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25407,25407,,Not Active,5223883,[],CHEMBL1673755,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 at 4 times MIC after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25408,25408,,Not Active,5223884,[],CHEMBL1673756,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene at 4 times MIC after 1 hr by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25409,25409,,Active,5223885,[],CHEMBL1673757,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR at 4 times MIC after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25410,25410,,Not Active,5223886,[],CHEMBL1673758,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 at 4 times MIC after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25411,25411,,Not Active,5223887,[],CHEMBL1673759,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 at 4 times MIC after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25412,25412,,Not Active,5223888,[],CHEMBL1673885,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene at 4 times MIC after 3 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25413,25413,,Active,5223889,[],CHEMBL1673886,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR at 4 times MIC after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25414,25414,,Not Active,5223890,[],CHEMBL1674521,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 at 4 times MIC after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25415,25415,,Not Active,5223891,[],CHEMBL1674522,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 at 4 times MIC after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25416,25416,,Not Active,5223892,[],CHEMBL1674523,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene at 4 times MIC after 6 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25417,25417,,Active,5223893,[],CHEMBL1674524,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR at 4 times MIC after 24 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25418,25418,,Not Active,5223894,[],CHEMBL1674525,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 at 4 times MIC after 24 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25419,25419,,Not Active,5223895,[],CHEMBL1674526,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 at 4 times MIC after 24 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25420,25420,,Not Active,5223896,[],CHEMBL1674527,"Bactericidal activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene at 4 times MIC after 24 hrs by time kill analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
25421,25421,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5223897,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '2.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.5'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1674528,"Cmax in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg, sc administered as single dose after 15 mins by liquid chromatography",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1332043,=,1,1,=,,Cmax,nM,,3319.75,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,1.1
25422,25422,,,5223898,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '2.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.5'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1674529,"AUC (0 to 24 hrs) in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg, sc administered as single dose after 15 mins by liquid chromatography",A,,,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,1,=,,AUC,ng.hr.mL-1,,6200.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,microg/hr/ml,,,6.2
25423,25423,,,5223899,[],CHEMBL1674530,"Ratio of Cmax in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,147.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,147.0
25424,25424,,,5223900,[],CHEMBL1674531,"Ratio of Cmax in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,2.2,CHEMBL612545,,Unchecked,,,,Ratio,,,,2.2
25425,25425,,,5223901,[],CHEMBL1674532,"Ratio of Cmax in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,4.4,CHEMBL612545,,Unchecked,,,,Ratio,,,,4.4
25426,25426,,,5223902,[],CHEMBL1674533,"Ratio of Cmax in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,4.4,CHEMBL612545,,Unchecked,,,,Ratio,,,,4.4
25427,25427,,,5223903,[],CHEMBL1674534,"Ratio of AUC (0 to 24 hrs) in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,827.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,827.0
25428,25428,,,5223904,[],CHEMBL1674535,"Ratio of AUC (0 to 24 hrs) in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,12.4,CHEMBL612545,,Unchecked,,,,Ratio,,,,12.4
25429,25429,,,5223905,[],CHEMBL1674536,"Ratio of AUC (0 to 24 hrs) in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,24.8,CHEMBL612545,,Unchecked,,,,Ratio,,,,24.8
25430,25430,,,5223906,[],CHEMBL1674537,"Ratio of AUC (0 to 24 hrs) in immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg to MIC for rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,Ratio,,,24.8,CHEMBL612545,,Unchecked,,,,Ratio,,,,24.8
25431,25431,,,5223907,[],CHEMBL1674538,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR infected in immunocompetent CBA mouse assessed as bacterial count in kidney at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,3.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,3.6
25432,25432,,,5223908,[],CHEMBL1674659,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 infected in immunocompetent CBA mouse assessed as bacterial count in kidney at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,2.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,2.7
25433,25433,,,5223909,[],CHEMBL1674660,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 infected in immunocompetent CBA mouse assessed as bacterial count in kidney at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,4.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,4.2
25434,25434,,,5223910,[],CHEMBL1674661,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene infected in immunocompetent CBA mouse assessed as bacterial count in kidney at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,4.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,4.1
25435,25435,,,5223911,[],CHEMBL1674662,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR infected in immunocompetent CBA mouse assessed as bacterial count in bladder at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,4.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,4.2
25436,25436,,,5223912,[],CHEMBL1674663,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 infected in immunocompetent CBA mouse assessed as bacterial count in bladder at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,4.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,4.7
25437,25437,,,5223913,[],CHEMBL1674664,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 infected in immunocompetent CBA mouse assessed as bacterial count in bladder at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,5.0
25438,25438,,,5223914,[],CHEMBL1674665,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene infected in immunocompetent CBA mouse assessed as bacterial count in bladder at 2.5 mg/kg, sc administered twice daily for 2 days measured after 72 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,log10CFU/g,,,5.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/g,,,,5.4
25439,25439,,,5223915,[],CHEMBL1674666,Antimicrobial activity against qnr-negative Klebsiella pneumoniae C2 harboring qnrA1 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332043,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
25440,25440,,,5223916,[],CHEMBL1674667,"Protein binding in serum of immunocompetent CBA mouse infected with Escherichia coli at 2.5 mg/kg, sc administered as single dose",A,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332043,=,1,0,=,,Activity,%,,0.0,CHEMBL613590,Mus musculus,Serum,10090.0,,,Activity,%,UO_0000187,,0.0
25441,25441,,,5223917,[],CHEMBL1674668,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrA1 relative to rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,FC,,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,20.0
25442,25442,,,5223918,[],CHEMBL1674669,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR transconjugant harboring qnrS1 relative to rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,FC,,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,20.0
25443,25443,,,5223919,[],CHEMBL1674670,"Antimicrobial activity against rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR harboring gyrA mutant gene relative to rifampin-resistant, quinolone-susceptible Escherichia coli CFT703-RR",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671667,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332043,=,1,0,=,,FC,,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,20.0
25444,25444,,,5224609,[],CHEMBL1674649,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 902SA92 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
25445,25445,,,5224610,[],CHEMBL1674650,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 902SA92 harboring plasmid encoded RamR gene, GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
25446,25446,,,5224611,[],CHEMBL1674651,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 902SA92 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
25447,25447,,,5224612,[],CHEMBL1674652,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 102SA00 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,32.0
25448,25448,,,5224613,[],CHEMBL1674653,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 102SA00 harboring plasmid encoded RamR gene, GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
25449,25449,,,5224614,[],CHEMBL1674654,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 102SA00 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
25450,25450,,,5224615,[],CHEMBL1674655,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN10055 harboring GyrA S83Y mutant gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
25451,25451,,,5224616,[],CHEMBL1674656,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN10055 harboring plasmid encoded RamR gene, GyrA S83Y mutant gene by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
25452,25452,,,5224617,[],CHEMBL1675438,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN10055 harboring GyrA S83Y mutant gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
25453,25453,,,5224618,[],CHEMBL1675439,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 543SA98 harboring GyrA S83F mutant gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
25454,25454,,,5224619,[],CHEMBL1675440,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 543SA98 harboring plasmid encoded RamR gene, GyrA S83Y mutant gene by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.125
25455,25455,,,5224620,[],CHEMBL1675441,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 543SA98 harboring GyrA S83Y mutant gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.125
25456,25456,,,5224621,[],CHEMBL1675442,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9945 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
25457,25457,,,5224622,[],CHEMBL1675443,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9945 harboring plasmid encoded RamR gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.125
25458,25458,,,5224623,[],CHEMBL1675444,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN9945 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.125
25459,25459,,,5224624,[],CHEMBL1675445,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9181 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25460,25460,,,5224625,[],CHEMBL1675446,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9181 harboring plasmid encoded RamR gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25461,25461,,,5224626,[],CHEMBL1675447,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN9181 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.0075,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.0075
25462,25462,,,5224627,[],CHEMBL1675448,Antimicrobial activity against Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25463,25463,,,5224628,[],CHEMBL1675449,Antimicrobial activity against marR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25464,25464,,,5224629,[],CHEMBL1675450,Antimicrobial activity against marR-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25465,25465,,,5224630,[],CHEMBL1675451,Antimicrobial activity against marA::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25466,25466,,,5224631,[],CHEMBL1675452,Antimicrobial activity against soxR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25467,25467,,,5224632,[],CHEMBL1675453,Antimicrobial activity against soxS::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25468,25468,,,5224633,[],CHEMBL1675454,Antimicrobial activity against Salmonella enterica serovar Typhimurium S/921495 harboring plasmid encoded RamR gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25469,25469,,,5224634,[],CHEMBL1675455,Antimicrobial activity against ramR-deficient Salmonella enterica serovar Typhimurium S/921495 harboring plasmid encoded RamR gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25470,25470,,,5224635,[],CHEMBL1675456,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25471,25471,,,5224636,[],CHEMBL1675457,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25472,25472,,,5224637,[],CHEMBL1675458,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18 harboring plasmid encoded RamR gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25473,25473,,,5224638,[],CHEMBL1675459,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
25474,25474,,,5224639,[],CHEMBL1675460,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/21 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.125
25475,25475,,,5224640,[],CHEMBL1675461,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/21 harboring plasmid encoded RamR gene by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
25476,25476,,,5224641,[],CHEMBL1675462,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/21 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
25477,25477,,,5224642,[],CHEMBL1675463,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/41 harboring GyrA G81C,acrR mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
25478,25478,,,5224643,[],CHEMBL1675570,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/41 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
25479,25479,,,5224644,[],CHEMBL1675571,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/41 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
25480,25480,,,5224645,[],CHEMBL1675572,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/71 harboring GyrA G81C, acrR mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
25481,25481,,,5224646,[],CHEMBL1675573,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/71 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
25482,25482,,,5224647,[],CHEMBL1675574,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/71 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
25483,25483,,,5224648,[],CHEMBL1675575,Antimicrobial activity against ramR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
25484,25484,,,5224649,[],CHEMBL1675576,Antimicrobial activity against ramR-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671854,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331597,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
25485,25485,,,5225352,[],CHEMBL1679664,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332068,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,16.0
25486,25486,,,5225364,[],CHEMBL1679794,Antibacterial activity against Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332068,>=,1,1,>=,,MIC90,ug.mL-1,,0.06,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC90,ug ml-1,UO_0000274,,0.06
25487,25487,,,5225379,[],CHEMBL1679806,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.3
25488,25488,,,5225383,[],CHEMBL1679807,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,1.3
25489,25489,,,5225387,[],CHEMBL1679808,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,16.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,16.6
25490,25490,,,5225391,[],CHEMBL1679809,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,65.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,65.0
25491,25491,,,5225394,[],CHEMBL1679810,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,86.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,86.4
25492,25492,,,5225398,[],CHEMBL1679811,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,89.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,89.8
25493,25493,,,5225401,[],CHEMBL1679812,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,91.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,91.4
25494,25494,,,5225408,[],CHEMBL1679814,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
25495,25495,,,5225419,[],CHEMBL1679821,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.8
25496,25496,,,5225422,[],CHEMBL1679822,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,6.3
25497,25497,,,5225424,[],CHEMBL1679961,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,8.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,8.7
25498,25498,,,5225429,[],CHEMBL1679963,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,9.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,9.4
25499,25499,,,5225435,[],CHEMBL1679965,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
25500,25500,,,5225444,[],CHEMBL1680838,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.3
25501,25501,,,5225447,[],CHEMBL1680839,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,1.4
25502,25502,,,5225449,[],CHEMBL1680840,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,17.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,17.7
25503,25503,,,5225451,[],CHEMBL1680841,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,71.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,71.0
25504,25504,,,5225452,[],CHEMBL1680842,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,94.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,94.4
25505,25505,,,5225453,[],CHEMBL1680843,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,98.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,98.0
25506,25506,,,5225454,[],CHEMBL1680844,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
25507,25507,,,5225466,[],CHEMBL1680851,Antibacterial activity against non-levofloxacin susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
25508,25508,,,5225476,[],CHEMBL1680857,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.0
25509,25509,,,5225479,[],CHEMBL1680858,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,16.0
25510,25510,,,5225480,[],CHEMBL1680859,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,28.0
25511,25511,,,5225483,[],CHEMBL1680861,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,32.0
25512,25512,,,5225486,[],CHEMBL1680863,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
25513,25513,,,5225494,[],CHEMBL1680968,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,3.0
25514,25514,,,5225503,[],CHEMBL1680973,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
25515,25515,,,5225511,[],CHEMBL1680978,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,4.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,4.7
25516,25516,,,5225514,[],CHEMBL1680979,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,14.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,14.0
25517,25517,,,5225518,[],CHEMBL1680980,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,48.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,48.8
25518,25518,,,5225521,[],CHEMBL1680981,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,53.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,53.9
25519,25519,,,5225529,[],CHEMBL1679337,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,60.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,60.5
25520,25520,,,5225532,[],CHEMBL1679338,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,65.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,65.1
25521,25521,,,5225535,[],CHEMBL1679339,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
25522,25522,,,5225545,[],CHEMBL1679346,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,11.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,11.1
25523,25523,,,5225546,[],CHEMBL1679347,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
25524,25524,,,5225554,[],CHEMBL1679352,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,0.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.3
25525,25525,,,5225617,[],CHEMBL1677353,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS70 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332390,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
25526,25526,,,5225627,[],CHEMBL1677354,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332390,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
25527,25527,,,5225636,[],CHEMBL1677355,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS71 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332390,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
25528,25528,,,5225646,[],CHEMBL1677356,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS123 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332390,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
25529,25529,,,5225658,[],CHEMBL1677357,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332390,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
25530,25530,,,5225668,[],CHEMBL1677358,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS2 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332390,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
25531,25531,,,5225678,[],CHEMBL1677359,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS3 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671719,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332390,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
25532,25532,,Not Determined,5225756,[],CHEMBL1677380,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric assay,B,,,BAO_0002114,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332424,,1,0,,,Time,,,,CHEMBL612545,,Unchecked,,,,Time,,,,
25533,25533,,,5225783,[],CHEMBL1677379,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric assay,B,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,1332424,=,1,1,=,,TIME,hr,,0.005556,CHEMBL612545,,Unchecked,,,,Time,s,UO_0000032,,20.0
25534,25534,,,5226086,[],CHEMBL1674838,Antimicrobial activity against Escherichia coli isolate GZ3 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25535,25535,,,5226087,[],CHEMBL1674839,Antimicrobial activity against Escherichia coli isolate GZ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25536,25536,,,5226088,[],CHEMBL1674840,Antimicrobial activity against Escherichia coli isolate GZ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25537,25537,,,5226089,[],CHEMBL1674841,Antimicrobial activity against Escherichia coli isolate GZ6 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
25538,25538,,,5226090,[],CHEMBL1674842,Antimicrobial activity against Escherichia coli isolate GZ8 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25539,25539,,,5226091,[],CHEMBL1674843,Antimicrobial activity against Escherichia coli isolate GZ9 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25540,25540,,,5226092,[],CHEMBL1674844,Antimicrobial activity against Escherichia coli isolate GZ11 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25541,25541,,,5226093,[],CHEMBL1674845,Antimicrobial activity against Escherichia coli isolate GZ12 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25542,25542,,,5226094,[],CHEMBL1674846,Antimicrobial activity against Escherichia coli isolate GZ13 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
25543,25543,,,5226095,[],CHEMBL1674847,Antimicrobial activity against Escherichia coli isolate GZ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25544,25544,,,5226096,[],CHEMBL1674848,Antimicrobial activity against Escherichia coli isolate GZ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25545,25545,,,5226097,[],CHEMBL1674849,Antimicrobial activity against Escherichia coli isolate GZ16 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25546,25546,,,5226098,[],CHEMBL1674850,Antimicrobial activity against Escherichia coli isolate CQ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
25547,25547,,,5226099,[],CHEMBL1674851,Antimicrobial activity against Escherichia coli isolate CQ18 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
25548,25548,,,5226100,[],CHEMBL1674852,Antimicrobial activity against Escherichia coli isolate CQ2 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,3.0
25549,25549,,,5226101,[],CHEMBL1674853,Antimicrobial activity against Escherichia coli isolate CQ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
25550,25550,,,5226102,[],CHEMBL1674854,Antimicrobial activity against Escherichia coli isolate CQ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
25551,25551,,,5226103,[],CHEMBL1674855,Antimicrobial activity against Escherichia coli isolate CQ20 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
25552,25552,,,5226104,[],CHEMBL1674856,Antimicrobial activity against Escherichia coli isolate CQ26 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25553,25553,,,5226105,[],CHEMBL1674857,Antimicrobial activity against Escherichia coli isolate CQ10 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25554,25554,,,5226106,[],CHEMBL1674972,Antimicrobial activity against Escherichia coli isolate CQ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25555,25555,,,5226107,[],CHEMBL1674973,Antimicrobial activity against Escherichia coli isolate GZ7 transconjugant harboring 16S rRNA methylase RmtB and qepA and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
25556,25556,,,5226108,[],CHEMBL1674974,Antimicrobial activity against Escherichia coli isolate GZ1 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
25557,25557,,,5226109,[],CHEMBL1674975,Antimicrobial activity against Escherichia coli isolate GZ2 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25558,25558,,,5226110,[],CHEMBL1674976,Antimicrobial activity against Escherichia coli isolate CQ22 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
25559,25559,,,5226111,[],CHEMBL1674977,Antimicrobial activity against Escherichia coli isolate CQ13 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25560,25560,,,5226112,[],CHEMBL1674978,"Antimicrobial activity against Escherichia coli isolate CQ6 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
25561,25561,,,5226113,[],CHEMBL1674979,"Antimicrobial activity against Escherichia coli isolate CQ7 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25562,25562,,,5226114,[],CHEMBL1674980,"Antimicrobial activity against Escherichia coli isolate CQ12 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25563,25563,,,5226115,[],CHEMBL1674981,"Antimicrobial activity against Escherichia coli isolate CQ16 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
25564,25564,,,5226116,[],CHEMBL1674982,"Antimicrobial activity against Escherichia coli isolate GZ10 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
25565,25565,,,5226117,[],CHEMBL1674983,"Antimicrobial activity against Escherichia coli isolate CQ19 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
25566,25566,,,5226118,[],CHEMBL1674984,Antimicrobial activity against Escherichia coli isolate CQ1 transconjugant harboring 16S rRNA methylase RmtB and qnrB6 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1331642,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
25567,25567,,,5226652,[],CHEMBL1680339,Antimicrobial activity against multidrug-resistant Acinetobacter baumannii assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671632,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1331857,=,1,0,=,,Activity,%,,95.9,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,95.9
25568,25568,,,5226682,[],CHEMBL1679353,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,0.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.6
25569,25569,,,5226686,[],CHEMBL1679354,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,1.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,1.8
25570,25570,,,5226689,[],CHEMBL1679355,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,24.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,24.7
25571,25571,,,5226692,[],CHEMBL1679356,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,65.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,65.3
25572,25572,,,5226694,[],CHEMBL1679357,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,95.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,95.7
25573,25573,,,5226697,[],CHEMBL1679510,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,98.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,98.2
25574,25574,,,5226699,[],CHEMBL1679511,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,99.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.1
25575,25575,,,5226702,[],CHEMBL1679512,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
25576,25576,,,5226712,[],CHEMBL1679519,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,6.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,6.3
25577,25577,,,5226714,[],CHEMBL1679520,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,28.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,28.1
25578,25578,,,5226716,[],CHEMBL1679521,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,90.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,90.6
25579,25579,,,5226718,[],CHEMBL1679522,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,96.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,96.9
25580,25580,,,5226719,[],CHEMBL1679523,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
25581,25581,,,5226724,[],CHEMBL1679527,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,2.5
25582,25582,,,5226728,[],CHEMBL1679528,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,9.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,9.9
25583,25583,,,5226731,[],CHEMBL1679529,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,43.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,43.2
25584,25584,,,5226735,[],CHEMBL1679530,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,64.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,64.2
25585,25585,,,5226738,[],CHEMBL1679531,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,66.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,66.7
25586,25586,,,5226739,[],CHEMBL1679532,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,67.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,67.9
25587,25587,,,5226741,[],CHEMBL1679533,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
25588,25588,,,5226750,[],CHEMBL1680375,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,15.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,15.8
25589,25589,,,5226754,[],CHEMBL1680376,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,23.7,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,23.7
25590,25590,,,5226757,[],CHEMBL1680377,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,26.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,26.3
25591,25591,,,5226761,[],CHEMBL1680378,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,28.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,28.9
25592,25592,,,5226764,[],CHEMBL1680379,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,100.0
25593,25593,,,5226773,[],CHEMBL1680385,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,67.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,67.4
25594,25594,,,5226777,[],CHEMBL1680386,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,69.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,69.1
25595,25595,,,5226781,[],CHEMBL1680387,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,72.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,72.8
25596,25596,,,5226785,[],CHEMBL1680388,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,74.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,74.1
25597,25597,,,5226789,[],CHEMBL1680389,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,75.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,75.3
25598,25598,,,5226793,[],CHEMBL1680390,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,75.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,75.5
25599,25599,,,5226796,[],CHEMBL1680391,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,75.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,75.6
25600,25600,,,5226799,[],CHEMBL1680392,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,80.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,80.1
25601,25601,,,5226803,[],CHEMBL1680393,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
25602,25602,,,5226815,[],CHEMBL1680524,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,73.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,73.9
25603,25603,,,5226819,[],CHEMBL1680525,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,79.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,79.9
25604,25604,,,5226823,[],CHEMBL1680526,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,85.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,85.4
25605,25605,,,5226827,[],CHEMBL1680527,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,91.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,91.5
25606,25606,,,5226831,[],CHEMBL1680528,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,92.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,92.0
25607,25607,,,5226835,[],CHEMBL1680529,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,93.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,93.0
25608,25608,,,5226839,[],CHEMBL1680530,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,93.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,93.5
25609,25609,,,5226843,[],CHEMBL1680531,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,94.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,94.5
25610,25610,,,5226846,[],CHEMBL1680532,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,100.0
25611,25611,,,5226854,[],CHEMBL1680536,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,93.8,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,93.8
25612,25612,,,5226858,[],CHEMBL1680537,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,96.9,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,96.9
25613,25613,,,5226861,[],CHEMBL1680538,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,100.0
25614,25614,,,5226867,[],CHEMBL1680541,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,88.9,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,88.9
25615,25615,,,5226871,[],CHEMBL1680542,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,90.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,90.3
25616,25616,,,5226878,[],CHEMBL1680545,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,91.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,91.7
25617,25617,,,5226883,[],CHEMBL1681164,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,97.2,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,97.2
25618,25618,,,5226887,[],CHEMBL1679398,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,98.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,98.6
25619,25619,,,5226891,[],CHEMBL1679399,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,100.0
25620,25620,,,5226895,[],CHEMBL1679401,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,63.6,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,63.6
25621,25621,,,5226897,[],CHEMBL1679402,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,72.7,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,72.7
25622,25622,,,5226901,[],CHEMBL1679403,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,78.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,78.8
25623,25623,,,5226905,[],CHEMBL1679404,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,81.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,81.8
25624,25624,,,5226909,[],CHEMBL1679405,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,84.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,84.8
25625,25625,,,5226912,[],CHEMBL1679406,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,100.0
25626,25626,,,5226925,[],CHEMBL1679545,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,7.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,7.3
25627,25627,,,5226929,[],CHEMBL1679546,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,27.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,27.7
25628,25628,,,5226932,[],CHEMBL1679547,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,53.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,53.3
25629,25629,,,5226936,[],CHEMBL1679548,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,65.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,65.0
25630,25630,,,5226940,[],CHEMBL1679549,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,74.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,74.5
25631,25631,,,5226944,[],CHEMBL1679550,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,79.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,79.6
25632,25632,,,5226948,[],CHEMBL1679551,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,85.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,85.4
25633,25633,,,5226952,[],CHEMBL1679552,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,90.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,90.5
25634,25634,,,5226956,[],CHEMBL1679553,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,100.0
25635,25635,,,5226965,[],CHEMBL1679559,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,3.8,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,3.8
25636,25636,,,5226973,[],CHEMBL1679563,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,7.7,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,7.7
25637,25637,,,5226977,[],CHEMBL1679564,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,34.6,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,34.6
25638,25638,,,5226981,[],CHEMBL1679565,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,69.2,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,69.2
25639,25639,,,5226984,[],CHEMBL1679566,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,80.8,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,80.8
25640,25640,,,5226988,[],CHEMBL1679567,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,100.0
25641,25641,,,5226995,[],CHEMBL1679571,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,13.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,13.3
25642,25642,,,5226999,[],CHEMBL1679572,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,53.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,53.3
25643,25643,,,5227003,[],CHEMBL1679704,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,80.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,80.0
25644,25644,,,5227007,[],CHEMBL1679705,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,86.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,86.7
25645,25645,,,5227009,[],CHEMBL1679706,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,1.0
25646,25646,,,5227013,[],CHEMBL1679707,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1332068,=,1,0,=,,Activity,%,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,100.0
25647,25647,,,5227625,[],CHEMBL1674985,Antibacterial activity against Klebsiella pneumoniae isolate Kp1239 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
25648,25648,,,5227626,[],CHEMBL1674986,Antibacterial activity against Klebsiella pneumoniae isolate Kp1945 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 and dfrA12-orfF-aadA2 arrays by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
25649,25649,,,5227627,[],CHEMBL1674987,Antibacterial activity against Klebsiella pneumoniae isolate Kp2730 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 and dfrA12-orfF-aadA2 arrays by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
25650,25650,,,5227628,[],CHEMBL1674988,Antibacterial activity against Enterobacter cloacae isolate El3280 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,2.0
25651,25651,,,5227629,[],CHEMBL1675780,Antibacterial activity against Enterobacter cloacae isolate El3518 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
25652,25652,,,5227630,[],CHEMBL1675781,Antibacterial activity against Citrobacter amalonaticus isolate Ca3927 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL615077,Citrobacter amalonaticus,Citrobacter amalonaticus,35703.0,,,MIC,ug ml-1,UO_0000274,,0.5
25653,25653,,,5227631,[],CHEMBL1675782,Antibacterial activity against Enterobacter cloacae isolate El1573 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,2.0
25654,25654,,,5227632,[],CHEMBL1675783,Antibacterial activity against Serratia marcescens isolate Sm2723 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,2.0
25655,25655,,,5227633,[],CHEMBL1675784,Antibacterial activity against Klebsiella pneumoniae isolate Kp7564 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25656,25656,,,5227634,[],CHEMBL1675785,Antibacterial activity against Citrobacter amalonaticus isolate Ca38009 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL615077,Citrobacter amalonaticus,Citrobacter amalonaticus,35703.0,,,MIC,ug ml-1,UO_0000274,,0.5
25657,25657,,,5227635,[],CHEMBL1675786,Antibacterial activity against Klebsiella pneumoniae isolate Kp38009 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
25658,25658,,,5227636,[],CHEMBL1675787,Antibacterial activity against Morganella morganii isolate Mm38009 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.5
25659,25659,,,5227637,[],CHEMBL1675788,Antibacterial activity against Klebsiella pneumoniae isolate Kp38045 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25660,25660,,,5227638,[],CHEMBL1675789,Antibacterial activity against Escherichia coli isolate Ec9381 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25661,25661,,,5227639,[],CHEMBL1675790,Antibacterial activity against Morganella morganii isolate Mm1229 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.5
25662,25662,,,5227640,[],CHEMBL1675791,Antibacterial activity against Enterobacter cloacae isolate El3799 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.5
25663,25663,,,5227641,[],CHEMBL1675792,Antibacterial activity against Klebsiella pneumoniae isolate Kp3799 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25664,25664,,,5227642,[],CHEMBL1675793,Antibacterial activity against Klebsiella oxytoca isolate Ko0426 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.5
25665,25665,,,5227643,[],CHEMBL1675794,Antibacterial activity against Klebsiella oxytoca isolate Ko1156 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.5
25666,25666,,,5227644,[],CHEMBL1675795,Antibacterial activity against Citrobacter amalonaticus isolate Ca1614 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL615077,Citrobacter amalonaticus,Citrobacter amalonaticus,35703.0,,,MIC,ug ml-1,UO_0000274,,0.5
25667,25667,,,5227645,[],CHEMBL1675796,Antibacterial activity against Citrobacter freundii isolate Cf1614 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.5
25668,25668,,,5227646,[],CHEMBL1675797,Antibacterial activity against Morganella morganii isolate Mm1614 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.5
25669,25669,,,5227647,[],CHEMBL1675798,Antibacterial activity against Klebsiella pneumoniae isolate Kp4614,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25670,25670,,,5227648,[],CHEMBL1675799,Antibacterial activity against Escherichia coli isolate Ec158 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25671,25671,,,5227649,[],CHEMBL1675800,Antibacterial activity against Klebsiella pneumoniae isolate Kp149 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
25672,25672,,,5227650,[],CHEMBL1675801,Antibacterial activity against Serratia marcescens isolate Sm220 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,2.0
25673,25673,,,5227651,[],CHEMBL1675802,Antibacterial activity against Serratia marcescens isolate Sm201 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,2.0
25674,25674,,,5227652,[],CHEMBL1675803,Antibacterial activity against Serratia marcescens isolate Sm203 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,2.0
25675,25675,,,5227653,[],CHEMBL1675804,Antibacterial activity against Klebsiella pneumoniae isolate Kp211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25676,25676,,,5227654,[],CHEMBL1675805,Antibacterial activity against Escherichia coli isolate Ec211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25677,25677,,,5227655,[],CHEMBL1675806,Antibacterial activity against Klebsiella pneumoniae isolate Kp266 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25678,25678,,,5227656,[],CHEMBL1675807,Antibacterial activity against Serratia marcescens isolate Sm211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,2.0
25679,25679,,,5227657,[],CHEMBL1675808,Antibacterial activity against Citrobacter koseri isolate Ck211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC,ug ml-1,UO_0000274,,0.5
25680,25680,,,5227658,[],CHEMBL1675809,Antibacterial activity against Enterobacter cloacae isolate El216 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.5
25681,25681,,,5227659,[],CHEMBL1675810,Antibacterial activity against Escherichia coli isolate Ec221 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25682,25682,,,5227660,[],CHEMBL1675811,Antibacterial activity against Klebsiella oxytoca isolate Ko238 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.5
25683,25683,,,5227661,[],CHEMBL1675812,Antibacterial activity against Klebsiella pneumoniae isolate Kp204 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25684,25684,,,5227662,[],CHEMBL1675813,Antibacterial activity against Serratia marcescens isolate Sm265 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.5
25685,25685,,,5227663,[],CHEMBL1675814,Antibacterial activity against Acinetobacter isolate A74510 harboring blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,2.0
25686,25686,,,5227664,[],CHEMBL1675815,Antibacterial activity against Acinetobacter baumannii isolate AbN450 harboring IblaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
25687,25687,,,5227665,[],CHEMBL1673445,Antibacterial activity against Citrobacter youngae isolate CyB38 harboring blaIMP-4-qacG2-aacA4-catB3 array by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671859,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331650,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,2.0
25688,25688,,,5228070,[],CHEMBL1679709,Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332073,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
25689,25689,,,5228071,[],CHEMBL1679710,Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332073,=,1,1,=,,MIC,ug.mL-1,,0.0005,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0005
25690,25690,,,5228072,[],CHEMBL1679711,Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332073,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
25691,25691,,,5228073,[],CHEMBL1679712,Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332073,=,1,1,=,,MIC,ug.mL-1,,0.0005,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0005
25692,25692,,,5228074,[],CHEMBL1680414,Ratio of MIC for Escherichia coli KAM32 harboring plasmid pUC18 to MIC for Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332073,=,1,0,=,,Ratio,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,2.0
25693,25693,,,5228075,[],CHEMBL1680415,Antibacterial activity against Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332073,=,1,1,=,,MIC,ug.mL-1,,120.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,120.0
25694,25694,,,5228076,[],CHEMBL1680416,Antibacterial activity against abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332073,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,40.0
25695,25695,,,5228077,[],CHEMBL1680417,Ratio of MIC for Acinetobacter baumannii AC0037 to MIC for abeS-deficient Acinetobacter baumannii AC0037,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332073,=,1,0,=,,Ratio,,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Ratio,,,,3.0
25696,25696,,,5228078,[],CHEMBL1680418,Antibacterial activity against abeS sigma abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332073,>,1,1,>,,MIC,ug.mL-1,,60.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,60.0
25697,25697,,,5228527,[],CHEMBL1678018,Antimicrobial activity against Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25698,25698,,,5228528,[],CHEMBL1678019,Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
25699,25699,,,5228529,[],CHEMBL1678020,Antimicrobial activity against ESBL-production Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.12
25700,25700,,,5228530,[],CHEMBL1678022,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.25
25701,25701,,,5228531,[],CHEMBL1678023,Antimicrobial activity against Acinetobacter baumannii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.12
25702,25702,,,5228532,[],CHEMBL1678024,Antimicrobial activity against multiple dug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
25703,25703,,,5228533,[],CHEMBL1678025,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
25704,25704,,,5228534,[],CHEMBL1678026,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,0.5
25705,25705,,,5228553,[],CHEMBL1678018,Antimicrobial activity against Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,4.0
25706,25706,,,5228554,[],CHEMBL1678019,Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
25707,25707,,,5228555,[],CHEMBL1678020,Antimicrobial activity against ESBL-production Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25708,25708,,,5228556,[],CHEMBL1678022,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25709,25709,,,5228557,[],CHEMBL1678023,Antimicrobial activity against Acinetobacter baumannii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25710,25710,,,5228558,[],CHEMBL1678024,Antimicrobial activity against multiple dug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,4.0
25711,25711,,,5228559,[],CHEMBL1678025,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25712,25712,,,5228560,[],CHEMBL1678026,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25713,25713,,,5228579,[],CHEMBL1678018,Antimicrobial activity against Escherichia coli by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,2.0
25714,25714,,,5228580,[],CHEMBL1678019,Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
25715,25715,,,5228581,[],CHEMBL1678020,Antimicrobial activity against ESBL-production Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,8.0
25716,25716,,,5228582,[],CHEMBL1678022,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,2.0
25717,25717,,,5228583,[],CHEMBL1678023,Antimicrobial activity against Acinetobacter baumannii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,0.25
25718,25718,,,5228584,[],CHEMBL1678024,Antimicrobial activity against multiple dug-resistant Acinetobacter baumannii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,2.0
25719,25719,,,5228585,[],CHEMBL1678025,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,8.0
25720,25720,,,5228586,[],CHEMBL1678026,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332499,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC50,ug ml-1,UO_0000274,,2.0
25721,25721,,,5228775,[],CHEMBL1675357,Antibacterial activity against Campylobacter by Etest,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671860,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331655,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,32.0
25722,25722,,,5230106,[],CHEMBL1676244,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZN10 containing cat and bla genes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332570,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
25723,25723,,,5230107,[],CHEMBL1676245,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2396-encoded QacA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332570,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
25724,25724,,,5230108,[],CHEMBL1676246,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2182-encoded QacBII gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332570,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
25725,25725,,,5230109,[],CHEMBL1676247,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332570,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
25726,25726,,,5230110,[],CHEMBL1676248,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII E320A mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332570,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
25727,25727,,,5230111,[],CHEMBL1676249,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332570,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
25728,25728,,Not Determined,5230112,[],CHEMBL1676250,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A19T mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332570,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
25729,25729,,Not Determined,5230113,[],CHEMBL1676251,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV S151I mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332570,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
25730,25730,,Not Determined,5230114,[],CHEMBL1676252,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A184V mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332570,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
25731,25731,,Not Determined,5230115,[],CHEMBL1676253,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV E377G mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332570,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
25732,25732,,Active,5230116,[],CHEMBL1676254,Activity of antiseptic efflux protein QacBIII expressed in Staphylococcus aureus RDN1 assessed as decrease in compound accumulation,B,,,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332570,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
25733,25733,,Not Active,5230117,[],CHEMBL1676255,Activity of antiseptic efflux protein QacBIII expressed in Staphylococcus aureus RDN1 assessed as decrease in compound accumulation in presence of CCCP,B,,,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1332570,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
25734,25734,,,5230311,[],CHEMBL1679681,Antimicrobial activity against Clostridium difficile harboring ribotype 001 by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,mg/L,UO_0000274,,64.0
25735,25735,,,5230312,[],CHEMBL1679681,Antimicrobial activity against Clostridium difficile harboring ribotype 001 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,8.0
25736,25736,,,5230313,[],CHEMBL1679680,Antimicrobial activity against Clostridium difficile harboring ribotype 027 by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,mg/L,UO_0000274,,128.0
25737,25737,,,5230314,[],CHEMBL1679680,Antimicrobial activity against Clostridium difficile harboring ribotype 027 by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,mg/L,UO_0000274,,128.0
25738,25738,,,5230315,[],CHEMBL1679680,Antimicrobial activity against Clostridium difficile harboring ribotype 027 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,8.0
25739,25739,,,5230316,[],CHEMBL1679681,Antimicrobial activity against Clostridium difficile harboring ribotype 001 by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,mg/L,UO_0000274,,64.0
25740,25740,,,5230317,[],CHEMBL1679682,Antimicrobial activity against Clostridium difficile harboring other ribotypes by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,8.0
25741,25741,,,5230318,[],CHEMBL1679682,Antimicrobial activity against Clostridium difficile harboring other ribotypes by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,mg/L,UO_0000274,,16.0
25742,25742,,,5230319,[],CHEMBL1679682,Antimicrobial activity against Clostridium difficile harboring other ribotypes by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1671865,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331687,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,mg/L,UO_0000274,,128.0
25743,25743,,,5294657,[],CHEMBL1695593,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as survival rate at 30 mg/kg, ip every 12 hrs for 14 days treated 24 hrs postinfection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337231,=,1,0,=,,Survival,%,,90.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Survival,%,UO_0000187,,90.0
25744,25744,,,5294667,[],CHEMBL1695603,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as survival rate at 30 mg/kg, ip every 12 hrs for 14 days treated 36 hrs postinfection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337231,=,1,0,=,,Survival,%,,70.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Survival,%,UO_0000187,,70.0
25745,25745,,,5294668,[],CHEMBL1695604,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as survival rate at 30 mg/kg, ip every 12 hrs for 14 days treated 48 hrs postinfection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337231,=,1,0,=,,Survival,%,,80.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Survival,%,UO_0000187,,80.0
25746,25746,,,5294669,[],CHEMBL1695608,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as survival rate at 30 mg/kg, iv administered as single dose treated 24 hrs before infection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337231,=,1,0,=,,Survival,%,,0.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Survival,%,UO_0000187,,0.0
25747,25747,,,5294674,[],CHEMBL1695613,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as bacterial load per gram of lung tissue at 30 mg/kg, ip every 12 hrs for 14 days treated 24 hrs postinfection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337231,=,1,0,=,,log10cfu,,,1090.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,log10cfu,,,,1090.0
25748,25748,,,5294684,[],CHEMBL1695725,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as bacterial load per gram of lung tissue at 30 mg/kg, ip every 12 hrs for 14 days treated 36 hrs postinfection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337231,=,1,0,=,,log10cfu,,,2880.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,log10cfu,,,,2880.0
25749,25749,,,5294685,[],CHEMBL1695726,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as bacterial load per gram of lung tissue at 30 mg/kg, ip every 12 hrs for 14 days treated 48 hrs postinfection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337231,=,1,0,=,,log10cfu,,,3080.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,log10cfu,,,,3080.0
25750,25750,,Not Determined,5294689,[],CHEMBL1695730,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as bacterial load per gram of lung tissue at 30 mg/kg, iv administered as single dose treated 24 hrs before infection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337231,,1,0,,,log10cfu,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,log10cfu,,,,
25751,25751,,,5294701,[],CHEMBL1696208,Antimicrobial activity against Bacillus cereus ATCC 4342 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337231,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.12
25752,25752,,,5294703,[],CHEMBL1696209,Antimicrobial activity against Bacillus cereus ATCC 4342 selected after 20 daily cycles of drug selection followed by 5 days of nonselective growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337231,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.5
25753,25753,,,5294705,[],CHEMBL1696210,Ratio of MIC for Bacillus cereus ATCC 4342 selected after 20 daily cycles of drug selection followed by 5 days of nonselective growth to MIC for Bacillus cereus ATCC 4342,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337231,=,1,0,=,,Ratio,,,4.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,Ratio,,,,4.0
25754,25754,,,5294706,[],CHEMBL1696211,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as survival rate at 30 mg/kg, ip administered as two doses treated 24 and 12 hrs before infection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337231,=,1,0,=,,Survival,%,,0.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Survival,%,UO_0000187,,0.0
25755,25755,,Not Determined,5294707,[],CHEMBL1696212,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as bacterial load per gram of lung tissues at 30 mg/kg, ip administered as two doses treated 24 and 12 hrs before infection",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337231,,1,0,,,log10cfu,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,log10cfu,,,,
25756,25756,,,5294712,[],CHEMBL1696214,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as survival rate at 30 mg/kg, ip treated 24 and 12 hrs before infection measured on day 3",F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337231,=,1,0,=,,Activity,%,,100.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,%,UO_0000187,,100.0
25757,25757,,,5294713,[],CHEMBL1696215,"Antimicrobial activity against Bacillus anthracis infected mouse spore inhalation anthrax model assessed as survival rate at 30 mg/kg, iv administered as two doses treated 24 hrs before infection measured on day 3",F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687708,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1337231,=,1,0,=,,Activity,%,,100.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,%,UO_0000187,,100.0
25758,25758,,Dose-dependent effect,5296067,[],CHEMBL1691742,Inactivation of Pseudomonas putida PAW340 biofilms assessed as decrease in heat production by Chip calorimetry,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337750,,1,0,,,Activity,,,,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,,Activity,,,,
25759,25759,,Active,5296076,[],CHEMBL1691750,Antibacterial activity against Pseudomonas putida PAW340 assessed as decrease in bacterial count at 20 to 150 ug/ml,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687754,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337750,,1,0,,,Activity,,,,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,,Activity,,,,
25760,25760,,,5296464,[],CHEMBL1692056,Antimicrobial activity against beta-lactamase AmpC producing meropenem-resistant Serratia marcescens by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687811,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338232,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.12
25761,25761,,,5296473,[],CHEMBL1692057,Antimicrobial activity against azide-resistant Escherichia coli J53 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687811,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338232,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
25762,25762,,,5296482,[],CHEMBL1692058,Antimicrobial activity against Serratia marcescens ATCC 8100 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687811,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338232,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,8.0
25763,25763,,Not Active,5297768,[],CHEMBL1690575,Antimicrobial activity against Acinetobacter lwoffii isolate A expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25764,25764,,Not Active,5297769,[],CHEMBL1690576,Antimicrobial activity against Acinetobacter lwoffii isolate B expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25765,25765,,Not Active,5297770,[],CHEMBL1690577,Antimicrobial activity against Acinetobacter lwoffii isolate C expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25766,25766,,Not Active,5297771,[],CHEMBL1690578,Antimicrobial activity against Acinetobacter lwoffii isolate D expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25767,25767,,Not Active,5297772,[],CHEMBL1690579,Antimicrobial activity against Acinetobacter lwoffii isolate E expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25768,25768,,Not Active,5297773,[],CHEMBL1690580,Antimicrobial activity against Acinetobacter lwoffii isolate F expressing beta-lactamase OXA-164 isolated from tracheostoma of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25769,25769,,Not Active,5297774,[],CHEMBL1690581,Antimicrobial activity against Acinetobacter lwoffii isolate G expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25770,25770,,Not Active,5297775,[],CHEMBL1690582,Antimicrobial activity against Acinetobacter lwoffii isolate H expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25771,25771,,Not Active,5297776,[],CHEMBL1690583,Antimicrobial activity against Acinetobacter lwoffii isolate I expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25772,25772,,Not Active,5297777,[],CHEMBL1690584,Antimicrobial activity against Acinetobacter lwoffii isolate J expressing beta-lactamase OXA-58 isolated from bedsore by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25773,25773,,Not Active,5297778,[],CHEMBL1690585,Antimicrobial activity against Acinetobacter lwoffii isolate K expressing beta-lactamase OXA-58 isolated from blood culture of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25774,25774,,Not Active,5297779,[],CHEMBL1690703,Antimicrobial activity against Acinetobacter lwoffii isolate L expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25775,25775,,Not Active,5297780,[],CHEMBL1690704,Antimicrobial activity against Acinetobacter lwoffii isolate M expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1338412,,1,0,,,MIC,,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,,,,
25776,25776,,,5298888,[],CHEMBL1690006,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687822,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338444,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
25777,25777,,,5298889,[],CHEMBL1690007,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 335913,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687822,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338444,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
25778,25778,,,5298890,[],CHEMBL1690008,Antibacterial activity against Mycobacterium smegmatis MC2 155 ATCC,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687822,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338444,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
25779,25779,,,5299678,[],CHEMBL1691813,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25780,25780,,,5299679,[],CHEMBL1691809,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25781,25781,,,5299680,[],CHEMBL1691807,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25782,25782,,,5299686,[],CHEMBL1691812,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25783,25783,,,5299687,[],CHEMBL1691810,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25784,25784,,,5299688,[],CHEMBL1691806,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25785,25785,,,5299694,[],CHEMBL1691811,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25786,25786,,,5299695,[],CHEMBL1691808,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25787,25787,,,5299696,[],CHEMBL1691805,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.1
25788,25788,,,5299702,[],CHEMBL1691804,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25789,25789,,,5299703,[],CHEMBL1691803,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25790,25790,,,5299704,[],CHEMBL1691814,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25791,25791,,,5299710,[],CHEMBL1691804,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
25792,25792,,,5299711,[],CHEMBL1691803,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
25793,25793,,,5299712,[],CHEMBL1691814,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25794,25794,,,5299718,[],CHEMBL1691815,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25795,25795,,,5299719,[],CHEMBL1691816,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25796,25796,,,5299720,[],CHEMBL1691817,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25797,25797,,,5299726,[],CHEMBL1691815,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
25798,25798,,,5299727,[],CHEMBL1691816,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
25799,25799,,,5299728,[],CHEMBL1691817,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
25800,25800,,,5299734,[],CHEMBL1691818,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
25801,25801,,,5299735,[],CHEMBL1692614,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25802,25802,,,5299736,[],CHEMBL1692615,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25803,25803,,,5299742,[],CHEMBL1691818,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
25804,25804,,,5299743,[],CHEMBL1692614,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25805,25805,,,5299744,[],CHEMBL1692615,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25806,25806,,,5299750,[],CHEMBL1692616,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
25807,25807,,,5299751,[],CHEMBL1692617,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
25808,25808,,,5299752,[],CHEMBL1692618,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25809,25809,,,5299758,[],CHEMBL1692616,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
25810,25810,,,5299759,[],CHEMBL1692617,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25811,25811,,,5299760,[],CHEMBL1692618,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25812,25812,,,5299766,[],CHEMBL1692619,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25813,25813,,,5299767,[],CHEMBL1692620,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
25814,25814,,,5299768,[],CHEMBL1692621,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25815,25815,,,5299769,[],CHEMBL1692622,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25816,25816,,,5299770,[],CHEMBL1692623,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25817,25817,,,5299771,[],CHEMBL1692624,"Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25818,25818,,,5299772,[],CHEMBL1692625,"Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25819,25819,,,5299773,[],CHEMBL1692626,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
25820,25820,,,5299774,[],CHEMBL1692627,"Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25821,25821,,,5299775,[],CHEMBL1692628,"Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25822,25822,,,5299776,[],CHEMBL1692629,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
25823,25823,,,5299777,[],CHEMBL1692630,"Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25824,25824,,,5299778,[],CHEMBL1692631,"Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25825,25825,,,5299779,[],CHEMBL1692632,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25826,25826,,,5299780,[],CHEMBL1692633,"Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25827,25827,,,5299781,[],CHEMBL1692634,"Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25828,25828,,,5299782,[],CHEMBL1692635,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25829,25829,,,5299783,[],CHEMBL1692636,"Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25830,25830,,,5299784,[],CHEMBL1692637,"Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25831,25831,,,5299785,[],CHEMBL1692771,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25832,25832,,,5299786,[],CHEMBL1692772,"Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25833,25833,,,5299787,[],CHEMBL1692773,"Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25834,25834,,,5299788,[],CHEMBL1692774,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25835,25835,,,5299789,[],CHEMBL1692775,"Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25836,25836,,,5299790,[],CHEMBL1692776,"Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25837,25837,,,5299791,[],CHEMBL1692777,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25838,25838,,,5299792,[],CHEMBL1692778,"Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25839,25839,,,5299793,[],CHEMBL1692779,"Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25840,25840,,,5299794,[],CHEMBL1692780,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
25841,25841,,,5299795,[],CHEMBL1692781,"Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25842,25842,,,5299796,[],CHEMBL1692782,"Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25843,25843,,,5299797,[],CHEMBL1692783,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25844,25844,,,5299798,[],CHEMBL1692784,"Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25845,25845,,,5299799,[],CHEMBL1692785,"Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25846,25846,,,5299800,[],CHEMBL1692786,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25847,25847,,,5299801,[],CHEMBL1692787,"Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25848,25848,,,5299802,[],CHEMBL1692788,"Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25849,25849,,,5299803,[],CHEMBL1692789,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25850,25850,,,5299804,[],CHEMBL1692790,"Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25851,25851,,,5299805,[],CHEMBL1692791,"Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25852,25852,,,5299806,[],CHEMBL1692792,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
25853,25853,,,5299807,[],CHEMBL1692793,"Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25854,25854,,,5299808,[],CHEMBL1692794,"Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25855,25855,,,5299809,[],CHEMBL1692795,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
25856,25856,,,5299810,[],CHEMBL1692796,"Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25857,25857,,,5299811,[],CHEMBL1692797,"Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25858,25858,,,5299812,[],CHEMBL1692798,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25859,25859,,,5299813,[],CHEMBL1692799,"Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25860,25860,,,5299814,[],CHEMBL1693545,"Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25861,25861,,,5299815,[],CHEMBL1693546,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25862,25862,,,5299816,[],CHEMBL1693547,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25863,25863,,,5299817,[],CHEMBL1693548,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25864,25864,,,5299818,[],CHEMBL1693549,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25865,25865,,,5299819,[],CHEMBL1693550,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25866,25866,,,5299820,[],CHEMBL1693551,"Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25867,25867,,,5299821,[],CHEMBL1693552,"Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25868,25868,,,5299822,[],CHEMBL1693553,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25869,25869,,,5299823,[],CHEMBL1693554,"Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25870,25870,,,5299824,[],CHEMBL1693555,"Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25871,25871,,,5299825,[],CHEMBL1693556,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25872,25872,,,5299826,[],CHEMBL1693557,"Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25873,25873,,,5299827,[],CHEMBL1693558,"Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25874,25874,,,5299828,[],CHEMBL1693559,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25875,25875,,,5299829,[],CHEMBL1693560,"Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25876,25876,,,5299830,[],CHEMBL1693561,"Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25877,25877,,,5299831,[],CHEMBL1693562,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25878,25878,,,5299832,[],CHEMBL1693670,"Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25879,25879,,,5299833,[],CHEMBL1693671,"Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25880,25880,,,5299834,[],CHEMBL1693672,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25881,25881,,,5299835,[],CHEMBL1693673,"Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25882,25882,,,5299836,[],CHEMBL1693674,"Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25883,25883,,,5299837,[],CHEMBL1693675,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25884,25884,,,5299838,[],CHEMBL1693676,"Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25885,25885,,,5299839,[],CHEMBL1693677,"Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25886,25886,,,5299840,[],CHEMBL1693678,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25887,25887,,,5299841,[],CHEMBL1693679,"Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25888,25888,,,5299842,[],CHEMBL1693680,"Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25889,25889,,,5299843,[],CHEMBL1693681,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
25890,25890,,,5299844,[],CHEMBL1693682,"Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25891,25891,,,5299845,[],CHEMBL1693683,"Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25892,25892,,,5299846,[],CHEMBL1693684,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25893,25893,,,5299847,[],CHEMBL1693685,"Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25894,25894,,,5299848,[],CHEMBL1693686,"Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25895,25895,,,5299849,[],CHEMBL1693687,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25896,25896,,,5299850,[],CHEMBL1693688,"Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25897,25897,,,5299851,[],CHEMBL1693689,"Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25898,25898,,,5299852,[],CHEMBL1693690,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25899,25899,,,5299853,[],CHEMBL1693691,"Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25900,25900,,,5299854,[],CHEMBL1693692,"Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25901,25901,,,5299855,[],CHEMBL1693693,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25902,25902,,,5299856,[],CHEMBL1693694,"Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25903,25903,,,5299857,[],CHEMBL1693695,"Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25904,25904,,,5299858,[],CHEMBL1694465,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25905,25905,,,5299859,[],CHEMBL1694466,"Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25906,25906,,,5299860,[],CHEMBL1694467,"Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25907,25907,,,5299861,[],CHEMBL1694468,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25908,25908,,,5299862,[],CHEMBL1694469,"Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25909,25909,,,5299863,[],CHEMBL1694470,"Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25910,25910,,,5299864,[],CHEMBL1694471,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
25911,25911,,,5299865,[],CHEMBL1694472,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25912,25912,,,5299866,[],CHEMBL1694473,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25913,25913,,,5299867,[],CHEMBL1694474,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25914,25914,,,5299868,[],CHEMBL1694475,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25915,25915,,,5299869,[],CHEMBL1694476,"Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25916,25916,,,5299870,[],CHEMBL1694477,"Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25917,25917,,,5299871,[],CHEMBL1694478,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25918,25918,,,5299872,[],CHEMBL1694479,"Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25919,25919,,,5299873,[],CHEMBL1694480,"Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25920,25920,,,5299874,[],CHEMBL1694481,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
25921,25921,,,5299875,[],CHEMBL1694482,"Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25922,25922,,,5299876,[],CHEMBL1694597,"Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25923,25923,,,5299877,[],CHEMBL1694598,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25924,25924,,,5299878,[],CHEMBL1694599,"Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25925,25925,,,5299879,[],CHEMBL1694600,"Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25926,25926,,,5299880,[],CHEMBL1694601,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25927,25927,,,5299881,[],CHEMBL1694602,"Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25928,25928,,,5299882,[],CHEMBL1694603,"Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25929,25929,,,5299883,[],CHEMBL1694604,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25930,25930,,,5299884,[],CHEMBL1694605,"Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25931,25931,,,5299885,[],CHEMBL1694606,"Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25932,25932,,,5299886,[],CHEMBL1694607,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25933,25933,,,5299887,[],CHEMBL1694608,"Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25934,25934,,,5299888,[],CHEMBL1694609,"Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25935,25935,,,5299889,[],CHEMBL1694610,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25936,25936,,,5299890,[],CHEMBL1694611,"Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25937,25937,,,5299891,[],CHEMBL1694612,"Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25938,25938,,,5299892,[],CHEMBL1694613,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25939,25939,,,5299893,[],CHEMBL1694614,"Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25940,25940,,,5299894,[],CHEMBL1694615,"Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
25941,25941,,,5299895,[],CHEMBL1694616,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25942,25942,,,5299896,[],CHEMBL1694617,"Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25943,25943,,,5299897,[],CHEMBL1694618,"Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
25944,25944,,,5299898,[],CHEMBL1694619,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
25945,25945,,,5299899,[],CHEMBL1694620,"Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25946,25946,,,5299900,[],CHEMBL1694621,"Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
25947,25947,,,5299901,[],CHEMBL1696090,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
25948,25948,,,5299902,[],CHEMBL1696091,"Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25949,25949,,,5299903,[],CHEMBL1696092,"Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25950,25950,,,5299904,[],CHEMBL1696093,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25951,25951,,,5299905,[],CHEMBL1696094,"Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25952,25952,,,5299906,[],CHEMBL1696095,"Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25953,25953,,,5299907,[],CHEMBL1696096,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
25954,25954,,,5299908,[],CHEMBL1696097,"Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25955,25955,,,5299909,[],CHEMBL1696098,"Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25956,25956,,,5299910,[],CHEMBL1696099,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
25957,25957,,,5299911,[],CHEMBL1696100,"Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
25958,25958,,,5299912,[],CHEMBL1696101,"Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338447,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
25959,25959,,,5302379,[],CHEMBL1694428,Antituberculosis activity against Mycobacterium tuberculosis MYC5165 harboring InhA mutant gene after 7 days by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687909,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1336749,=,1,1,=,,MIC,nM,,5000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,5.0
25960,25960,,,5302384,[],CHEMBL1694429,Antituberculosis activity against Mycobacterium tuberculosis 1400 harboring KatG mutant gene after 7 days by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687909,J Med Chem,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,1336749,=,1,1,=,,MIC,nM,,5000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,5.0
25961,25961,,Active,5304156,[],CHEMBL1690073,"Antimicrobial activity against Bacillus anthracis Ames infected in BALB/c mouse anthrax spore inhalation infection model assessed as decrease in tissue bacterial burden at 30 mg/kg, ip bid for 14 days administered 24 hrs post bacterial challenge measured 43 days post bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337839,,1,0,,,Activity,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,,,,
25962,25962,,Active,5304157,[],CHEMBL1690074,"Antimicrobial activity against Bacillus anthracis Ames infected in BALB/c mouse anthrax spore inhalation infection model assessed as decrease in tissue bacterial burden at 30 mg/kg, ip bid for 21 days administered 24 hrs post bacterial challenge measured 43 days post bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687771,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1337839,,1,0,,,Activity,,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,Activity,,,,
25963,25963,,,5304589,[],CHEMBL1695034,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent resistant isolates after 24 hrs by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1338518,=,1,0,=,,Activity,%,,28.2,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,%,UO_0000187,,28.2
25964,25964,,,5304590,[],CHEMBL1695035,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates assessed as percent susceptible isolates after 24 hrs by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,1338518,=,1,0,=,,Activity,%,,70.5,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,%,UO_0000187,,70.5
25965,25965,,,5304591,[],CHEMBL1695040,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338518,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC50,ug ml-1,UO_0000274,,0.06
25966,25966,,,5304592,[],CHEMBL1695040,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338518,>,1,1,>,,MIC90,ug.mL-1,,0.5,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC90,ug ml-1,UO_0000274,,0.5
25967,25967,,,5304639,[],CHEMBL1695040,Antimicrobial activity against Neisseria gonorrhoeae clinical isolates after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687841,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338518,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.06
25968,25968,,,5305647,[],CHEMBL1690402,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae ATCC 138821 by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
25969,25969,,,5305648,[],CHEMBL1690403,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.5
25970,25970,,,5305649,[],CHEMBL1690404,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.015
25971,25971,,,5305650,[],CHEMBL1690405,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.5
25972,25972,,,5305651,[],CHEMBL1690406,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
25973,25973,,,5305652,[],CHEMBL1690407,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,1.0
25974,25974,,,5305653,[],CHEMBL1690408,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
25975,25975,,,5305654,[],CHEMBL1690409,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,2.0
25976,25976,,,5305655,[],CHEMBL1690410,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.06
25977,25977,,,5305656,[],CHEMBL1690411,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.25
25978,25978,,,5305657,[],CHEMBL1690412,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.015
25979,25979,,,5305658,[],CHEMBL1690413,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.5
25980,25980,,,5305659,[],CHEMBL1690414,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
25981,25981,,,5305660,[],CHEMBL1690415,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.06
25982,25982,,,5305661,[],CHEMBL1690416,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.015
25983,25983,,,5305662,[],CHEMBL1690417,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.125
25984,25984,,,5305663,[],CHEMBL1690418,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337862,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
25985,25985,,,5307323,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
25986,25986,,,5307324,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
25987,25987,,,5307325,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
25988,25988,,,5307326,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
25989,25989,,,5307327,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
25990,25990,,,5307328,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25991,25991,,,5307329,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
25992,25992,,,5307330,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
25993,25993,,,5307331,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
25994,25994,,,5307332,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25995,25995,,,5307333,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
25996,25996,,,5307334,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
25997,25997,,,5307335,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
25998,25998,,,5307336,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
25999,25999,,,5307337,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338560,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
